Mitochondrial fatty acid oxidation in obesity
Open accessAbstract
SIGNIFICANCE: Current lifestyles with high-energy diets and little exercise are triggering an alarming growth in obesity. Excess of adiposity is leading to severe increases in associated pathologies, such as insulin resistance, type 2 diabetes, atherosclerosis, cancer, arthritis, asthma, and hypertension. This, together with the lack of efficient obesity drugs, is the driving force behind much research. RECENT ADVANCES: Traditional anti-obesity strategies focused on reducing food intake and increasing physical activity. However, recent results suggest that enhancing cellular energy expenditure may be an attractive alternative therapy. CRITICAL ISSUES: This review evaluates recent discoveries regarding mitochondrial fatty acid oxidation (FAO) and its potential as a therapy for obesity. We focus on the still controversial beneficial effects of increased FAO in liver and muscle, recent studies on how to potentiate adipose tissue energy expenditure, and the different hypotheses involving FAO and the reactive oxygen species production in the hypothalamic control of food intake. FUTURE DIRECTIONS: The present review aims to provide an overview of novel anti-obesity strategies that target mitochondrial FAO and that will definitively be of high interest in the future research to fight against obesity-related disorders.
AI snapshot
Written from the paper’s full text.
TL;DR
This review evaluates mitochondrial fatty acid oxidation (FAO) and its potential as an anti-obesity therapy, focusing on the controversial beneficial effects of increased FAO in liver and muscle, strategies to potentiate adipose tissue energy expenditure, and hypotheses linking FAO and reactive oxygen species (ROS) to hypothalamic control of food intake. It concludes that targeting FAO and cellular energy expenditure may offer future therapies for obesity and its associated diseases, though several open questions remain.
Key findings
- Enhancing liver FAO via overexpression of a malonyl-CoA-insensitive CPT1A mutant (CPT1AM) in obese rodents rescues impaired hepatic, muscle, and WAT insulin signaling and reduces steatosis, inflammation, and adiposity, without increasing ROS derivatives or liver injury.
- In skeletal muscle, the role of FAO is contested: exercise, direct CPT1 overexpression, and indirect CPT1 activation (AMPK activators, ACC2 knockout) improve insulin sensitivity, but a high-fat diet also induces muscle mitochondrial biogenesis and β-oxidation, and incomplete FAO with acylcarnitine accumulation correlates negatively with glucose tolerance.
- In WAT, direct CPT1A overexpression improves insulin sensitivity and suppresses inflammatory signaling, but there is still no evidence that increasing adipose tissue FAO decreases FFA-induced ROS production.
- In the hypothalamus, pharmacological and genetic inhibition of CPT1A reduces food intake; malonyl-CoA, LCFA-CoA, and ROS are all proposed mediators, with UCP2 acting as a ROS scavenger to maintain physiological NPY/AgRP expression.
Methods
This is a narrative review; no primary data, sample, or statistical analysis are reported. It synthesizes in vitro, rodent, and human studies on mitochondrial FAO across liver, WAT, BAT, skeletal muscle, and hypothalamus, and discusses CPT1/AMPK/sirtuin regulation, ROS biology, and anti-obesity drug status (Orlistat and Lorcaserin as the only FDA-approved weight-loss drugs at the time).
Limitations
The paper states several open questions: whether long-term increased energy expenditure triggers compensatory appetite enhancement; whether increased FAO could induce pathological ROS or incomplete oxidation products; whether FAO enhancement reaches a tissue-specific limit (e.g., BAT thermogenesis tied to environmental temperature); and whether improved mitochondrial FAO is physiologically relevant if the individual remains sedentary or warm. The text also makes evident that data on hepatic FAO rates and CPT1A activity in NAFLD/NASH are inconclusive due to differing models and parameters, and that the role of ROS in hypothalamic food-intake control requires further research.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 126 cited sources checked · 0 supported · 0 flagged
- Premisecitation
In a NASH rat model fed a methionine-choline-deficient diet, CPT1A activity and mitochondrial FAO were notably reduced despite increased CPT1A mRNA expression.
“In this study, a NASH rat model fed a methionine-choline-deficient diet had a notable reduction in CPT1A activity and mitochondrial FAO despite increased CPT1A mRNA expression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] source
Not checked in the free run.
- Premisecitation
When adipose tissue cannot store excess fat, lipids accumulate inappropriately in the liver, muscle, and pancreas.
“When the adipose tissue cannot store excess fat, lipids accumulate inappropriately in the liver, muscle, and pancreas.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [145] source
Not checked in the free run.
- Interpretationreasoning
Reduction in malonyl-CoA levels leads to an increase in CPT1 activity and FAO.
“In consequence, the reduction in malonyl-CoA levels leads to an increase in CPT1 activity and FAO.”
Quote in the paperSubstantial claim - Premisecitation
Formation of a 4-hydroxynonenal-CPT1 adduct caused by lipid peroxidation as a consequence of ROS overproduction is the main cause of impaired FAO and lipid removal from hepatocytes.
“The formation of a 4-hydroxynonenal-CPT1 adduct caused by lipid peroxidation as a consequence of ROS overproduction is the main cause of impaired FAO and lipid removal from hepatocytes.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [150] source
Not checked in the free run.
- Interpretationreasoning
The liver can deal with an increased flux of fatty acids into mitochondria, thus escaping liver injury.
“It seems that the liver can deal with an increased flux of FA into the mitochondria, thus escaping from liver injury.”
Quote in the paperSubstantial claim
- Interpretationreasoning
There is still no evidence that increasing adipose tissue fatty acid oxidation would decrease free fatty acid-induced ROS production.
“However, there is still no evidence that increasing adipose tissue FAO would decrease FFA-induced ROS production.”
Quote in the paperSubstantial claim - Premisecitation
Recent studies have shown beneficial effects of increased fatty acid oxidation and lipolysis in adipocytes, through direct CPT1A overexpression.
“Although the exact physiological role of FAO in WAT remains to be determined, recent studies have shown beneficial effects of increased FAO and lipolysis in adipocytes, through direct CPT1A overexpression.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] source
Not checked in the free run.
- Interpretationreasoning
Post-translational modifications of CPT1 caused by lipid peroxidation could decrease CPT1 activity and reverse initially activated FAO.
“The post-translational modifications of CPT1 caused by lipid peroxidation could, subsequently, decrease CPT1 activity and reverse initially activated FAO.”
Quote in the paperSubstantial claim - Premisecitation
Brown adipocytes are differentiated from white adipocytes because of their high expression of type 2 iodothyronine deiodinase (DIO2), the transcription coregulators PRDM16 and PGC-1α, and the lipolytic regulator Cidea.
“Brown adipocytes are also differentiated from white adipocytes because of their high expression of type 2 iodothyronnine deiodinase (DIO2), the transcription coregulators, PRDM16 and PGC-1α, and the lipolytic regulator, Cidea ([52](#B52), [131](#B131)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Interpretationreasoning
BAT plays a crucial role in protecting mice from diet-induced obesity.
“Therefore, BAT plays a crucial role in protecting mice from diet-induced obesity.”
Quote in the paperSubstantial claim - Interpretationreasoning
Any strategy able to switch liver fatty acid fate from esterification toward oxidation produces a beneficial effect on the liver and on the whole body.
“Taken together, these data support the idea that any strategy able to switch liver FA's fate from esterification toward oxidation produces a beneficial effect on the liver and on the whole body.”
Quote in the paperSubstantial claim - Premisecitation
Increased ROS in adipocytes exposed to excess free fatty acids does not depend on enhanced mitochondrial flux, but on high levels of TNFα and ER stress as well as upregulation of NOX enzymes.
“Recently, it has been demonstrated that increased ROS in adipocytes exposed to an excess of FFAs does not depend on enhanced mitochondrial flux, but on high levels of TNFα and ER stress as well as the upregulation of aforementioned NOX enzymes ([8](#B8), [60](#B60)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In 2009, five independent groups used PET-CT to identify the presence and study the relevance of BAT in adult humans.
“However, the real breakthrough arrived in 2009 when five independent groups used PET-CT to identify the presence and study the relevance of BAT in adult humans ([30](#B30), [143](#B143), [165](#B165), [168](#B168), [181](#B181)).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Premisecitation
Obese adipocytes and infiltrated immune cells secrete a large amount of inflammatory mediators that promote a proinflammatory state through activation of IKKβ-NF-Kβ and JNK-Ap1 signaling pathways.
“Obese adipocytes and infiltrated immune cells secrete a large amount of inflammatory mediators that promote a proinflammatory state through the activation of IKKβ-NF-Kβ and the JNK-Ap1 signaling pathways ([151](#B151)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [151] source
Not checked in the free run.
- Interpretationcitation
An increase of CPT1A is a new strategy for the treatment of NAFLD/NASH pathologies.
“Taken together, these results highlight an increase of CPT1A as a new strategy for the treatment of NAFLD/NASH pathologies.”
Quote in the paperSubstantial claim - Premisecitation
Activation of UCP1 uncouples aerobic respiration by producing heat instead of ATP.
“Activation of this protein uncouples aerobic respiration by producing heat instead of ATP ([162](#B162)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [162] source
Not checked in the free run.
- Premisecitation
ROS have the capacity to interfere with insulin signaling, since they activate several downstream pathways involving MAPK, JNK/IKKβ, and JAK/STAT, which are key contributors to the development of insulin resistance in obesity and type 2 diabetes.
“ROS have the capacity to interfere with insulin signaling, since they activate several downstream pathways involving MAPK, JNK/IKKβ, and JAK/STAT, which are key contributors to the development of insulin resistance in obesity and type 2 diabetes ([8](#B8), [75](#B75)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
In obesity, excess free fatty acids increase NOX-mediated ROS generation.
“In obesity, the excess of FFAs increases NOX-mediated ROS generation.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Expression of UCP1, DIO2, and the β3-adrenergic receptor was reported, indicating the potential responsiveness of human BAT to both hormonal and pharmacological stimuli.
“The expression of UCP1, DIO2, and the β3-adrenergic receptor was also reported, thereby indicating the potential responsiveness of human BAT to both hormonal and pharmacological stimuli.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
The combination of microhypoxia and lipid overload triggers the recruitment of immune cells, such as macrophages in adipose tissue, and their activation.
“The combination of microhypoxia and lipid overload triggers the recruitment of immune cells, such as macrophages in the adipose tissue and their activation ([103](#B103), [129](#B129), [171](#B171)).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Under excess caloric intake, white adipose tissue reaches its upper limit for further lipid storage.
“In fact, under excess caloric intake, WAT reaches its upper limit for further lipid storage ([157](#B157), [169](#B169)).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
Active BAT was observed to increase after cold exposure.
“In the course of using PET-CT to detect and stage tumors in humans, active BAT was observed to increase after cold exposure ([124](#B124)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [124] source
Not checked in the free run.
- Premisecitation
Direct CPT1 overexpression in animals and skeletal muscle cells protects muscle from fatty acid-induced insulin resistance and apoptosis.
“direct CPT1 overexpression in animals and SkM cells protects muscle from FA-induced insulin resistance and apoptosis ([15](#B15), [66](#B66), [149](#B149));”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Parallel with the increase in circulating lipids, the intramyocellular lipid content appears to increase proportionally in obese humans and rodents.
“Parallel with the increase in circulating lipids, the intramyocellular (IMC) lipid content appears to increase proportionally in obese humans ([105](#B105)) and rodents ([23](#B23)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Recent landmark studies have identified novel secreted proteins, such as liver FGF21, cardiac natriuretic peptides, and irisin, that stimulate brown adipocyte thermogenesis.
“Recent landmark studies have identified novel secreted proteins, such as liver FGF21 ([72](#B72)), cardiac natriuretic peptides ([11](#B11)), and irisin ([12](#B12)), that stimulate brown adipocyte thermogenesis.”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisecitation
Indirect skeletal muscle CPT1 activation, by the use of AMPK activators or the ACC2 knockout, ameliorates insulin-stimulated glucose uptake in rodents.
“indirect SkM CPT1 activation, by the use of AMPK activators ([77](#B77)) or the ACC2 knockout ([1](#B1)), ameliorates insulin-stimulated glucose uptake in rodents.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
These molecules activate proinflammatory and nutrient-sensing pathways that lead to the impairment of insulin action.
“These molecules activate proinflammatory and nutrient-sensing pathways that lead to the impairment of insulin action ([Fig. 6A](#f6)) [for further information, readers are referred to additional reviews ([144](#B144), [159](#B159))].”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
Skeletal muscle's capacity to oxidize substrates is far in excess of what is needed to supply the energy demands of resting muscle.
“First, it is known that SkM's capacity to oxidize substrates is far in excess of what is needed to supply the energy demands of resting muscle ([5](#B5)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [5] source
Not checked in the free run.
- Premisecitation
Altered UCP1 expression (UCP1-deficient or transgenic mice) leads to dysregulated sensitivity to cold exposure and body weight control.
“In fact, altered UCP1 expression (UCP1-deficient or transgenic mice) leads to dysregulated sensitivity to cold exposure and body weight control ([40](#B40), [42](#B42), [86](#B86), [87](#B87), [98](#B98)).”
Quote in the paperNot a substantial claim0 of 3 sources checked - Interpretationreasoning
Since fatty acids and glucose compete as metabolic substrates, a decrease in fatty acid oxidation would produce enhanced glucose utilization instead of insulin resistance.
“Secondly, since FA and glucose compete as metabolic substrates, the decrease in FAO would produce enhanced glucose utilization instead of insulin resistance.”
Quote in the paperSubstantial claim - Premisecitation
BAT burning power intensely clears and oxidizes circulating lipids and glucose to generate heat.
“Thus, BAT burning power intensely clears and oxidizes circulating lipids and glucose to generate heat ([17](#B17)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [17] source
Not checked in the free run.
- Interpretationreasoning
The mild (approximately 30%) reduction in mitochondrial content observed in obese patients does not affect the ability of resting muscle to oxidize fat.
“With this in mind, it seems clear that the mild (≈30%) reduction in mitochondrial content observed in obese patients does not affect the ability of resting muscle to oxidize fat.”
Quote in the paperSubstantial claim - Interpretationcitation
The effect of exercise on glucose tolerance and insulin sensitivity is probably due to increased CPT1 expression and activity during exercise.
“This effect is probably due to increased CPT1 expression and activity during exercise ([163](#B163));”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [163] source
Not checked in the free run.
- Premisecitation
Despite the reduction in mitochondrial content, insulin-resistant skeletal muscle has normal mitochondrial function.
“Further, despite the reduction in the mitochondrial content, insulin-resistant SkM has normal mitochondrial function ([13](#B13)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [13] source
Not checked in the free run.
- Premisecitation
The transition of skeletal muscle to an insulin-resistant state is central for the pathogenesis of type 2 diabetes.
“and its transition to an insulin-resistant state is central for the pathogenesis of type 2 diabetes ([152](#B152)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [152] source
Not checked in the free run.
- Premisecitation
Patients with severe mitochondrial deficiency have an increase in glucose uptake despite the large accumulation of intramyocellular lipids.
“In fact, patients with severe mitochondrial deficiency have an increase in glucose uptake despite the large accumulation of IMC lipids ([61](#B61)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [61] source
Not checked in the free run.
- Premisecitation
Free fatty acids and their metabolites (such as DAG and ceramides) are important contributors to lipid-induced insulin resistance in skeletal muscle.
“The lipotoxic hypothesis proposes that FAs and their metabolites (such as DAG and ceramides) are important contributors to lipid-induced insulin resistance in SkM.”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
SIRT1 activity is increased in the hypothalamus during starvation with high ghrelin levels.
“It is known that the SIRT1 activity is increased in hypothalamus during starvation with high ghrelin levels ([167](#B167)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [167] source
Not checked in the free run.
- Premisecitation
This increase, previous to active ghrelin rise, is an early reporter of a deficient nutritional state.
“This increase, previous to active ghrelin rise, is an early reporter of a deficient nutritional state ([156](#B156)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [156] source
Not checked in the free run.
- Premisecitation
During a pathophysiological state, a large and sustained increase in ROS impairs insulin action, through the activation of stress signaling pathways (i.e., MAPK and JNK), contributing to the pathogenesis of diet-induced insulin resistance.
“On the other hand, during a pathophysiological state, abundant evidence indicates that a large and sustained increase in ROS impairs insulin action, through the activation of stress signaling pathways (*i.e.,* MAPK and JNK) ([85](#B85), [154](#B154)), contributing to the pathogenesis of diet-induced insulin resistance ([67](#B67)).”
Quote in the paperSubstantial claim0 of 3 sources checked - Premisenone given
No cytoplasmic LCFA-CoA increase in the hypothalamus has been found.
“However, unfortunately, no cytoplasmic LCFA-CoA increase in hypothalamus has been found.”
Quote in the paperSubstantial claim - Premisecitation
During starvation, circulating free fatty acid increase can be sensed in hypothalamic nuclei through in-cell activation to LCFA-CoA.
“During starvation, circulating FFA increase can be sensed in hypothalamic nuclei through in-cell activation to LCFA-CoA.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [156] source
Not checked in the free run.
- Premisecitation
Pharmacological and genetic inhibition of hypothalamic CPT1A has been reported to reduce food intake.
“Even so, in the last decade, pharmacological and genetic inhibition of hypothalamic CPT1A has been reported to reduce the food intake ([10](#B10), [110](#B110), [127](#B127)), potentially as a result of LCFA-CoA cytoplasmic accumulation.”
Quote in the paperSubstantial claim0 of 3 sources checked - Interpretationcitation
Fatty acid oxidation intermediates may also create an unfavorable environment in the mitochondria, which contributes to the formation of ROS and the development of oxidative stress.
“FAO intermediates may also create an unfavorable environment in the mitochondria, which contributes to the formation of ROS and the development of oxidative stress ([119](#B119), [120](#B120)).”
Quote in the paperNot a substantial claim0 of 2 sources checked - Premisecitation
The phosphatases that negatively modulate the insulin pathway are the main targets for oxidative inhibition by ROS.
“In particular, the phosphatases that negatively modulate the insulin pathway are the main targets for oxidative inhibition by ROS ([35](#B35)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [35] source
Not checked in the free run.
- Premisecitation
High levels of ROS and systemic oxidative stress have been associated with obesity and insulin resistance.
“High levels of ROS and systemic oxidative stress have been associated with obesity and insulin resistance ([45](#B45)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [45] source
Not checked in the free run.
- Premisecitation
ROS enhance insulin sensitivity in high-fat-diet mice.
“It has also been reported that ROS enhance insulin sensitivity in HFD mice ([100](#B100)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [100] source
Not checked in the free run.
- Premisecitation
Transcription factors affected by changes in hypothalamic fatty acid oxidation, such as CREB, FoxO1, and BSX, are involved in ghrelin-induced expression of NPY and AgRP.
“Transcription factors affected by changes in hypothalamic FAO, such as CREB, FoxO1, and BSX, are involved in ghrelin-induced expression of NPY and AgRP ([92](#B92)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [92] source
Not checked in the free run.
- Premisecitation
ROS are crucial for the skeletal muscle remodeling that occurs in response to exercise.
“These molecules are also crucial for the SkM remodeling that occurs in response to exercise ([31](#B31)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [31] source
Not checked in the free run.
- Interpretationcitation
Mitochondrial accumulation of fatty acid oxidation intermediates triggers metabolic complications via protein modification.
“implies that mitochondrial accumulation of FAO intermediates triggers metabolic complications *via* protein modification ([71](#B71), [80](#B80)).”
Quote in the paperSubstantial claim0 of 2 sources checked - Premisecitation
During starvation, ACC phosphorylation is mainly controlled by AMPK.
“During starvation, ACC phosphorylation is mainly controlled by the well-known energy sensor, AMPK ([115](#B115)), which acts also as an important hub, integrating in-cell energetic state sensing and its modulation due to different circulating hormones.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [115] source
Not checked in the free run.
- Interpretationnone given
Beneficial effects of an increase in energy expenditure in obesity have been described in several tissues, including liver, muscle, WAT, and BAT.
“Beneficial effects of an increase in energy expenditure in obesity have been described in several tissues, including liver, muscle, WAT, and BAT.”
Quote in the paperNot a substantial claim - Interpretationreasoning
Thus, an increase in energy expenditure could indeed be the underlying protective mechanism against obesity-induced metabolic abnormalities.
“Thus, an increase in energy expenditure could indeed be the underlying protective mechanism against obesity-induced metabolic abnormalities.”
Quote in the paperSubstantial claim - Interpretationreasoning
A certain level of ROS, without being excessive, is probably required to trigger neuropeptide expression.
“A certain level of ROS, without being excessive, is probably required to trigger neuropeptide expression.”
Quote in the paperSubstantial claim - Premisecitation
Basal levels of fatty acid oxidation enzymes and fatty acid transport proteins (such as FATP-1, FATP-4, and FAT/CD36) are expressed in hypothalamic neurons.
“However, basal levels of FAO enzymes and FA transport proteins (such as FATP-1, FATP-4, and FAT/CD36) are expressed in hypothalamic neurons ([93](#B93), [95](#B95)).”
Quote in the paperSubstantial claim0 of 2 sources checked - Interpretationcitation
Fatty acid oxidation therapeutic inhibition in the hypothalamus seems to reduce food intake.
“On the contrary, FAO therapeutic inhibition in hypothalamus seems to reduce food intake.”
Quote in the paperSubstantial claim - Premisecitation
A direct correlation has been observed between fasting and free fatty acid levels.
“Nonetheless, the direct correlation observed between fasting and FFA levels ([156](#B156))”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [156] source
Not checked in the free run.
- May combine two claims. 37
- Classified as probably not a substantial claim. 13
May combine two claims.
PremisecitationMalonyl-CoA regulates FAO by inhibiting CPT1, making CPT1 the rate-limiting step in mitochondrial oxidation of fatty acids.
“Malonyl-CoA, a molecule derived from glucose metabolism and the first intermediate in lipogenesis, regulates FAO by inhibiting CPT1, thus making this enzyme the rate-limiting step in mitochondrial oxidation of FAs.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [109] source
Not checked in the free run.
May combine two claims.
InterpretationreasoningCPT1 overexpression and increased CPT1 activity occur in liver during onset of steatosis as a mechanism to compensate for increased fatty acid levels.
“The observations listed above suggest that CPT1 overexpression and increased CPT1 activity occur in liver during the onset of steatosis as a mechanism to compensate for increased FA levels.”
Quote in the paperSubstantial claimMay combine two claims.
InterpretationreasoningImbalance between lipid inputs and outputs results in lipid accumulation in hepatocytes, causing hepatosteatosis and insulin resistance.
“The imbalance between these inputs and outputs results in lipid accumulation in hepatocytes, which causes hepatosteatosis and insulin resistance.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenAccelerated mitochondrial FAO might cause excessive electron flux in the ETC and ROS overproduction.
“Accelerated mitochondrial FAO might cause excessive electron flux in the ETC and ROS overproduction.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningInfiltrated immune cells contribute to chronic low-grade inflammation, and increased inflammatory cytokines cause insulin resistance elsewhere in the body.
“Infiltrated immune cells also contribute to this chronic low-grade inflammatory milieu, whereby the increase in inflammatory cytokines causes insulin resistance elsewhere in the body.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningIncreased ROS might initiate lipid peroxidation, damage mitochondrial DNA and proteins, and alter mitochondrial morphology and function.
“As lipids, proteins, and mitochondrial DNA are the main ROS targets, increased ROS might initiate lipid peroxidation, damage mitochondrial DNA and proteins, and alter mitochondrial morphology and function.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationBAT thermogenesis takes place in its numerous, densely packed mitochondria, which contain BAT-specific UCP1.
“BAT thermogenesis takes place in its numerous, densely packed mitochondria, which contain the BAT-specific UCP1.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [162] source
Not checked in the free run.
May combine two claims.
PremisereasoningAdipocytes exceed their oxygen diffusion limit, promoting hypoxia, ER stress, and cell death.
“Consequently, adipocytes exceed their oxygen diffusion limit, thereby promoting hypoxia ([73](#B73)), ER stress ([132](#B132)), and cell death”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIncreased circulating free fatty acids and triglyceride accumulation in ectopic sites is produced.
“and increased circulating FFA and TG accumulation in ectopic sites is produced ([145](#B145)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [145] source
Not checked in the free run.
May combine two claims.
PremisecitationIn these studies, enhanced mitochondrial FAO did not increase ROS derivatives or liver injury.
“Furthermore, in these studies, enhanced mitochondrial FAO did not increase ROS derivatives or liver injury.”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationIn rodents, BAT generates heat mainly for two reasons: to protect against cold exposure via nonshivering thermogenesis and to burn excess calories and reduce fat accumulation.
“In rodents, BAT generates heat mainly for two reasons; namely, to protect against cold exposure *via* nonshivering thermogenesis and to burn the excess calories and reduce fat accumulation ([54](#B54), [72](#B72)).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationThis rise in lipid utilization improves insulin sensitivity in these cells and suppresses inflammatory signaling.
“In fact, this rise in lipid utilization improves insulin sensitivity in these cells and suppresses inflammatory signaling ([50](#B50)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [50] source
Not checked in the free run.
May combine two claims.
PremisecitationPhysiological ROS production in adipocytes is a relevant cellular signaling mechanism in the insulin response and depends mainly on NADPH oxidase (NOX) family activity.
“Physiological ROS production in adipocytes is a relevant cellular signaling mechanism in the insulin response and it depends mainly on the NADPH oxidase (NOX) family activity ([9](#B9)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [9] source
Not checked in the free run.
May combine two claims.
PremisecitationAll groups showed major depots of metabolically active fat in the cervical-supraclavicular region, a slightly different site from that in rodents and children, where BAT is found mainly in the interscapular area.
“All the groups showed major depots of metabolically active fat in the cervical–supraclavicular region, a slightly different site from that in rodents and children, where BAT is found mainly situated in the interscapular area.”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
InterpretationreasoningThese events cause insulin resistance in adipocytes, exacerbation of the inflammatory state, and systemic insulin resistance.
“These events cause insulin resistance in adipocytes, exacerbation of the inflammatory state, and systemic insulin resistance ([59](#B59), [147](#B147))”
Quote in the paperSubstantial claim0 of 2 sources checked- Rests on an assumption: The induction of JNK leads to serine phosphorylation of IRS-1 and 2, crucial molecules in insulin signaling, and consequently inhibits insulin action.
May combine two claims.
PremisecitationA high-fat diet causes insulin resistance in rodents, while inducing an increase in skeletal muscle mitochondrial biogenesis and β-oxidation.
“And finally, a HFD causes insulin resistance in rodents, while inducing an increase in SkM mitochondrial biogenesis and β-oxidation ([164](#B164)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [164] source
Not checked in the free run.
May combine two claims.
PremisecitationExercise in obese humans increases muscle mitochondrial fatty acid oxidation and improves glucose tolerance and insulin sensitivity.
“exercise in obese humans increases muscle mitochondrial FAO and improves glucose tolerance and insulin sensitivity ([16](#B16)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [16] source
Not checked in the free run.
May combine two claims.
PremisecitationHuman studies showed that BAT is reduced in obese and diabetic patients, indicating that this tissue participates in both cold-induced and diet-induced thermogenesis.
“Interestingly, human studies showed that BAT is reduced in obese and diabetic patients, thus indicating that this tissue participates in both cold-induced and diet-induced thermogenesis ([30](#B30)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [30] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSkeletal muscle accounts for approximately 80% of total glucose uptake after insulin stimulation.
“It accounts for ∼80% of total glucose uptake after insulin stimulation ([34](#B34))”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [34] source
Not checked in the free run.
May combine two claims.
PremisecitationMacrophages and the bone morphogenetic protein BMP8B have the capacity to regulate BAT thermogenesis.
“In addition, recent articles reported that macrophages ([125](#B125)) and the bone morphogenetic protein BMP8B ([172](#B172)) have also the capacity to regulate BAT thermogenesis.”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationA moderate increase (threefold) in irisin blood levels in mice enhanced energy expenditure and improved obesity and glucose homeostasis.
“Interestingly, a moderate increase (threefold) in irisin blood levels in mice enhanced energy expenditure and improved obesity and glucose homeostasis ([12](#B12)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [12] source
Not checked in the free run.
May combine two claims.
PremisecitationDifferent laboratories have demonstrated that a decrease in the size and number of mitochondria, the activity of proteins in the electron transport chain, and, in general, impaired oxidative capacity in skeletal muscle are associated with obesity and insulin resistance in humans and animals.
“Different laboratories have demonstrated that a decrease in the size and number of mitochondria, the activity of proteins in the ETC and, in general, impaired oxidative capacity in SkM are associated with obesity and insulin resistance in humans and animals ([102](#B102), [139](#B139), [153](#B153)).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
InterpretationcitationThis suggests that fatty acid oxidation might already be enhanced during obesity, contributing to the development of insulin resistance.
“This suggests that FAO might already be enhanced during obesity, contributing to the development of insulin resistance ([121](#B121)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [121] source
Not checked in the free run.
May combine two claims.
PremisecitationIncreased malonyl-CoA levels, which are generated by activated (i.e., dephosphorylated) ACC, act as abundance indicators, thereby diminishing food intake and consequently body weight.
“Strong evidence shows that increased malonyl-CoA levels, which are generated by activated (*i.e.,* dephosphorylated) ACC, act as abundance indicators, thereby diminishing food intake and consequently body weight ([173](#B173)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [173] source
Not checked in the free run.
May combine two claims.
PremisecitationROS are produced normally during mitochondrial respiration and are essential signal transducers that regulate several cell processes in skeletal muscle, including the insulin pathway.
“However, these molecules are produced normally during mitochondrial respiration and are essential signal transducers that regulate several cell processes in SkM ([8](#B8)), including the insulin pathway ([64](#B64), [65](#B65)).”
Quote in the paperSubstantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationSpecific hypothalamic nuclei sense nutrients and modify energy intake and expenditure to maintain a balance, and are responsible for regulating food intake.
“Specific hypothalamic nuclei, which sense nutrients and modify energy intake and expenditure to maintain a balance, are responsible for regulating this intake ([48](#B48)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [48] source
Not checked in the free run.
May combine two claims.
PremisecitationROS show insulin-like effects, stimulating skeletal muscle glucose uptake during muscle contraction via the activation of AMPK and the induction of PGC-1α expression in vitro and in vivo.
“ROS show insulin-like effects, stimulating SkM glucose uptake during muscle contraction *via* the activation of AMPK ([81](#B81)) and the induction of PGC-1α expression *in vitro* and *in vivo* ([57](#B57), [79](#B79)).”
Quote in the paperNot a substantial claim0 of 3 sources checkedMay combine two claims.
PremisecitationThe main problems associated with an increase in fatty acid oxidation are high rates of incomplete fat oxidation and an increase in oxidative stress associated with mitochondrial overload.
“The main problems associated with an increase in FAO are: (i) the high rates of incomplete fat oxidation and (ii) the increase in oxidative stress associated with a mitochondrial overload ([Fig. 6C](#f6)) ([89](#B89)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] source
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
PremisecitationKoves et al. postulated that a high-fat diet induces the expression of fatty acid oxidation-related genes, but not those associated with the electron transport chain and TCA cycle.
“Koves *et al.* ([89](#B89)) postulated that HFD induces the expression of FAO-related genes, but not those associated with the ETC and TCA cycle.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [89] source
Not checked in the free run.
May combine two claims.
PremisecitationThe mechanism of leptin action also appears to be related to increases in physiological malonyl-CoA in the arcuate nucleus, which promotes a reduction in food intake and body weight, using different mechanisms from those previously reported for ghrelin action, during energetically wealthy states.
“The mechanism of leptin action also appears to be related to increases in physiological malonyl-CoA in the arcuate nucleus, which promotes a reduction in food intake and body weight, using different mechanisms to those previously reported for ghrelin action, during energetically wealthy states ([49](#B49), [141](#B141)).”
Quote in the paperNot a substantial claim0 of 2 sources checkedMay combine two claims.
PremisecitationUnder physiological conditions, ROS are generated in response to insulin and are required for its action.
“On the one hand, under physiological conditions, ROS are generated in response to insulin and are required for its action ([69](#B69)), since the activity of different enzymes that participate in the insulin cascade are dependent on their oxidation state.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [69] source
Not checked in the free run.
May combine two claims.
PremisecitationSIRT3 knockout mice have high acylcarnitines and increased acylated mitochondrial proteins and develop metabolic syndrome.
“This along with the observation that SIRT3 knockout mice have high acylcarnitines and increased acylated mitochondrial proteins and develop metabolic syndrome, implies that mitochondrial accumulation of FAO intermediates triggers metabolic complications *via* protein modification ([71](#B71), [80](#B80)).”
Quote in the paperSubstantial claim0 of 2 sources checkedMay combine two claims.
InterpretationreasoningThis causes a mismatch between fatty acid oxidation and TCA cycle activity, leading to the accumulation of incomplete fatty acids and other intermediates (i.e., acylcarnitines) that correlate negatively with glucose tolerance.
“This causes a mismatch between FAO and TCA cycle activity, thus leading to the accumulation of incomplete FAs and other intermediates (*i.e.,* acylcarnitines) that correlate negatively with glucose tolerance ([2](#B2)).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [2] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationA recent finding is that hypothalamic autophagy is a source of endogenous free fatty acids to regulate AgRP levels.
“In addition to all these considerations, the recent finding that hypothalamic autophagy is a source of endogenous FFA to regulate AgRP levels ([82](#B82))”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [82] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationUCP2 acts as a ROS scavenger to keep a physiological ROS level that allows correct NPY and AgRP expression in the hypothalamus.
“This notion may explain the importance of UCP2 as a ROS scavenger to keep a physiological ROS level that allows correct NPY and AgRP expression in the hypothalamus ([6](#B6)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [6] source
Not checked in the free run.
May combine two claims.
InterpretationcitationThe presence of such small but functional fatty acid oxidation could be explained by its essential role in neuronal fatty acid turnover and its action as a lipid-sensing mediator for energy homeostasis.
“Additionally, the presence of such small, but functional FAO could be explained by its essential role in neuronal FA turnover and its action as a lipid-sensing mediator for energy homeostasis ([113](#B113)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [113] source
Not checked in the free run.
Probably not a substantial claim: may not pass S2 (checkable), S4 (based). May combine two claims.
Interpretationnone givenThere is no doubt regarding the involvement of ROS in pathophysiological processes related to obesity, and CPT1 seems to be a good molecular target for ROS and FAO modulation.
“There is no doubt regarding the involvement of ROS in pathophysiological processes related to obesity, and CPT1 seems to be a good molecular target for ROS and FAO modulation.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationSome authors pointed to complex I as the most relevant site for single electron reduction in brain mitochondria.
“Concretely, some authors pointed to complex I as the most relevant site for single electron reduction in brain mitochondria ([90](#B90)).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [90] source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationVarious kinases and transcription factors involved in neuropeptide regulation have been reported to be modulated by redox signaling.
“Various kinases and transcription factors, involved in neuropeptide regulation, have been reported to be modulated by redox signaling ([33](#B33), [91](#B91)).”
Quote in the paperNot a substantial claim0 of 2 sources checkedProbably not a substantial claim: may not pass S2 (checkable).
InterpretationreasoningAll of these could well alleviate the mitochondrial pressure found in lipid overload states.
“All of these could well alleviate the mitochondrial pressure found in lipid overload states.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMitochondrial ROS have been put forward as a mediator in response to nutrient availability.
“Along with malonyl-CoA and LCFA-CoA, mitochondrial ROS have been put forward as a mediator in response to nutrient availability ([140](#B140))”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [140] source
Not checked in the free run.
Probably not a substantial claim: may not pass S4 (based). May combine two claims.
Interpretationnone givenIncreased fatty acid oxidation may also decrease glucose oxidation to maintain energy homeostasis, augment mitochondrial burning capacity through an increase in the number of mitochondria and/or the increased expression of UCPs, and thus dissipate the excess of energy as heat and ATP.
“Increased FAO may also decrease glucose oxidation to maintain energy homeostasis, augment mitochondrial burning capacity through an increase in the number of mitochondria and/or the increased expression of UCPs, and thus dissipate the excess of energy as heat and ATP.”
Quote in the paperNot a substantial claimClassified as probably not a substantial claim. May combine two claims.
InterpretationcitationPotential mechanisms to explain the beneficial effects of targeting mitochondrial fatty acid oxidation could be the concomitant enhancement of hepatic ketone bodies, CO2, acid soluble products, ATP production, and endergonic processes (e.g., gluconeogenesis) seen in previous publications.
“Potential mechanisms to explain the beneficial effects of targeting mitochondrial FAO could be the concomitant enhancement of hepatic ketone bodies, CO2, acid soluble products, ATP production, and endergonic processes (*e.g.,* gluconeogenesis) seen in previous publications ([38](#B38), [130](#B130), [158](#B158)).”
Quote in the paperSubstantial claim0 of 3 sources checkedProbably not a substantial claim: may not pass S4 (based).
Premisenone givenMitochondrial fatty acid oxidation is the cell source of energy from fatty acids.
“Mitochondrial FAO is the cell source of energy from FAs.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationHypothalamic neurons have the capacity to sense glucose and free fatty acids simultaneously and to integrate other nutritional and hormonal inputs.
“and the capacity of hypothalamic neurons to sense glucose and FFA simultaneously and to integrate other nutritional and hormonal inputs ([95](#B95), [99](#B99))”
Quote in the paperSubstantial claim0 of 2 sources checked
The paper relies on this without support.
Obesity develops when energy intake exceeds energy expenditure.
“Obesity develops when energy intake exceeds energy expenditure.”
The paper relies on this without support.
Mammals have evolved mechanisms to store energy to survive during periods of starvation.
“mammals have evolved mechanisms to store energy to survive during periods of starvation”
The paper relies on this without support.
Homeostatic mechanisms increase caloric efficiency, making further weight loss more difficult.
“Such homeostatic mechanisms increase caloric efficiency, thus making further weight loss even more difficult.”
The paper relies on this without support.
Hormones such as insulin, glucagon, and noradrenaline control the extracellular uptake and intracellular release of carbohydrates and fatty acids.
“Hormones, such as insulin, glucagon, and noradrenaline, control the extracellular uptake and intracellular release of the main cell fuels; namely, carbohydrates and FAs.”
The paper relies on this without support.
Once inside the cell, fatty acids are esterified, metabolized to lipid second messengers, or β-oxidized in mitochondria.
“Once inside the cell, FAs are esterified, metabolized to lipid second messengers, or β-oxidized in mitochondria.”
The paper relies on this without support.
AMPK is one of the main regulators of the metabolic signaling network involving ACC, MCD, and CPT1.
“One of the main regulators of this network is the AMP-activated protein kinase (AMPK).”
The paper relies on this without support.
AMPK inhibits ATP-consuming processes while activating catabolic pathways.
“In general, AMPK inhibits ATP-consuming processes, while activating catabolic pathways.”
The paper relies on this without support.
Sirtuins are critical modulators of lipid metabolism and specifically of FAO.
“In recent years, sirtuins have emerged as critical modulators of lipid metabolism and specifically of FAO.”
The paper relies on this without support.
Energy flow in living cells (bioenergetics) takes place mainly in mitochondria.
“Energy flow in living cells (bioenergetics) takes place mainly in mitochondria.”
The paper relies on this without support.
Oxidative phosphorylation is the main source of reactive oxygen species (ROS) in the cell.
“This process is the main source of reactive oxygen species (ROS) in the cell.”
The paper relies on this without support.
In the ETC, the energy of electrons from NADH and FADH2 is used to pump protons from the mitochondrial matrix to the intermembrane space and generate the electrochemical gradient necessary for ATP synthesis.
“In the ETC, the energy of electrons from NADH and FADH2 is used to pump protons (H+) from the mitochondrial matrix to the intermembrane space and generate the electrochemical gradient necessary for ATP synthesis.”
The paper relies on this without support.
When electrons escape the ETC, ROS are produced in the mitochondria.
“However, when these electrons escape the ETC, ROS are produced in the mitochondria.”
The paper relies on this without support.
Mitochondrial ROS production is highly regulated and important for various cell functions, as ROS can act as signaling molecules.
“Mitochondrial ROS production is highly regulated and important for various cell functions, as ROS can act as signaling molecules.”
The paper relies on this without support.
In mitochondria, ETC complexes remain electron-bounded when the proton gradient is high, preventing outward pumping of H+ and increasing ROS production.
“In the mitochondria, the ETC complexes remain electron-bounded when the proton gradient between the mitochondrial matrix and the intermembrane space is high, preventing the outward pumping of H+ and increasing ROS production.”
The paper relies on this without support.
In BAT, UCP1 dissipates energy as heat and plays a key role in adaptive thermogenesis.
“In BAT, UCP1 dissipates energy as heat and plays a key role in adaptive thermogenesis.”
The paper relies on this without support.
The liver plays a central role in both energy expenditure and lipid/glucose homeostasis.
“The liver plays a central role in both energy expenditure and lipid/glucose homeostasis.”
The paper relies on this without support.
In conditions associated with prolonged excess of energy or impaired fatty acid metabolism, the liver stores considerable amounts of lipids in a process that leads to nonalcoholic fatty liver disease (NAFLD).
“In conditions associated with prolonged excess of energy or impaired FA metabolism, the liver stores considerable amounts of lipids in a process that leads to nonalcoholic fatty liver disease (NAFLD).”
The paper relies on this without support.
The mechanisms underlying NAFLD to NASH progression are not completely understood.
“The mechanisms underlying NAFLD to NASH progression are not completely understood.”
The paper relies on this without support.
Mitochondria play a vital role in the oxidation of fatty acids and ROS production.
“Mitochondria play a vital role in the oxidation of FAs and ROS production.”
The paper relies on this without support.
In the liver, mitochondrial FAO results either in complete oxidation to carbon dioxide or in partial oxidation to ketone bodies, which are exported to provide fuel for other tissues.
“In the liver, mitochondrial FAO results either in complete oxidation to carbon dioxide or in partial oxidation to ketone bodies, which are exported to provide fuel for other tissues.”
The paper relies on this without support.
Data on the rates of mitochondrial FAO and CPT1A activity in NAFLD/NASH are not conclusive, possibly because of the use of different models and parameters.
“Data on the rates of mitochondrial FAO and CPT1A activity in NAFLD/NASH are not conclusive, possibly because of the use of different models and parameters.”
The paper relies on this without support.
Results on CPT1A expression and activity are controversial.
“Similarly controversial results were obtained with CPT1A expression and activity.”
The paper relies on this without support.
The side effect of hepatic steatosis has interrupted the development of systemic CPT1 inhibitors such as etomoxir and 2-tetradecylglycidic acid as a therapeutic tool.
“This side effect has interrupted the development of other systemic inhibitors, such as etomoxir and 2-tetradecylglycidic acid, as a therapeutic tool.”
The paper relies on this without support.
Ketone bodies produced by enhanced FAO are easily consumed by other tissues, increasing the flux of carbons from liver to other organs.
“The ketone bodies produced by enhanced FAO are easily consumed by other tissues, increasing the flux of carbons from liver to other organs.”
The paper relies on this without support.
FGF21 has emerged as a key regulator in FAO and ketogenic activation.
“Recently, a new hepatic factor, fibroblast growth factor 21 (FGF21), has emerged as a key regulator in FAO and ketogenic activation.”
The paper relies on this without support.
WAT stores lipids mainly in the form of triglycerides, which can be mobilized and used to generate ATP through the mitochondrial β-oxidation pathway in peripheral organs during periods of caloric need.
“This long-term energy reservoir stores lipids mainly in the form of TGs, which can be mobilized and used to generate ATP through the mitochondrial β-oxidation pathway in peripheral organs during periods of caloric need.”
The paper relies on this without support.
Obesity is characterized by the expansion of white adipose tissue mass due to an increase in both adipocyte number (hyperplasia) and size (hypertrophy).
“Obesity is characterized by the expansion of WAT mass due to an increase in both adipocyte number (hyperplasia) and size (hypertrophy)”
The paper relies on this without support.
Obesity is closely associated with insulin resistance in peripheral tissues, such as skeletal muscle and liver.
“and it is closely associated with insulin resistance in peripheral tissues, such as SkM and liver.”
The paper relies on this without support.
The induction of JNK leads to serine phosphorylation of IRS-1 and 2, crucial molecules in insulin signaling, and consequently inhibits insulin action.
“The induction of JNK leads to serine phosphorylation of IRS-1 and 2, crucial molecules in insulin signaling, and consequently inhibits insulin action.”
The paper relies on this without support.
BAT is the only tissue to express UCP1.
“BAT is the only tissue to express UCP1, a protein found in the inner mitochondrial membrane that orchestrates the uncoupled reaction of allowing protons to re-enter the mitochondrial matrix without generating ATP.”
The paper relies on this without support.
UCP1 is a protein found in the inner mitochondrial membrane that orchestrates the uncoupled reaction of allowing protons to re-enter the mitochondrial matrix without generating ATP.
“BAT is the only tissue to express UCP1, a protein found in the inner mitochondrial membrane that orchestrates the uncoupled reaction of allowing protons to re-enter the mitochondrial matrix without generating ATP.”
The paper relies on this without support.
Body temperature changes stimulate norepinephrine release by sympathetic nervous endings that activate β-adrenergic receptors and trigger a signal transduction cascade that converts nutrients into acetyl-CoA.
“Body temperature changes stimulate norepinephrine release by sympathetic nervous endings that activate β-adrenergic receptors and trigger a signal transduction cascade that converts nutrients into acetyl-CoA.”
The paper relies on this without support.
Obesity is characterized by a greater breakdown and uptake of fatty acids.
“Obesity is characterized by a greater breakdown and uptake of FAs.”
The paper relies on this without support.
Mitochondrial members of the sirtuin family deacetylate/activate several proteins involved in fat oxidation.
“Mitochondrial members of the sirtuin family are known to deacetylate/activate several proteins involved in fat oxidation.”
The paper relies on this without support.
Ghrelin-mediated activation (i.e., phosphorylation) of AMPK is done via SIRT1-mediated activation (i.e., deacetylation) of p53.
“Concretely, ghrelin-mediated activation (*i.e.,* phosphorylation) of AMPK is done *via* SIRT1-mediated activation (*i.e.,* deacetylation) of p53.”
The paper relies on this without support.
Changes in feeding behavior and peripheral metabolism are conducted via the action of neuropeptides, such as agouti-related protein (AgRP), neuropeptide Y (NPY), and melanocortins.
“Regardless of whether malonyl-CoA or LCFA-CoA is the main actor, changes in feeding behavior and peripheral metabolism are conducted *via* the action of neuropeptides, such as agouti-related protein (AgRP), neuropeptide Y (NPY), and melanocortins.”
The paper relies on this without support.
ROS in the hypothalamus are produced chiefly in mitochondria electron transport chain complexes.
“ROS in the hypothalamus are produced chiefly in mitochondria ECT complexes.”
The paper relies on this without support.
Mitochondrial fatty acid oxidation is the cell source of energy from fatty acids.
“Mitochondrial FAO is the cell source of energy from FAs.”
The paper relies on this without support.
Current therapeutic strategies, focused mainly on controlling food intake, have met limited success, probably due to the inherent resistance of the human body to weight loss.
“Current therapeutic strategies, focused mainly on controlling food intake, have met limited success, probably due to the inherent resistance of the human body to weight loss.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Secreted proteins stimulate brown adipocyte thermogenesis and recruit brown or beige adipocytes to white adipose tissue.
“recent studies have identified secreted proteins that stimulate brown adipocyte thermogenesis and recruit brown (or beige) adipocytes to white adipose tissue [60] [61].”
From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [60]
FAO is activated in insulin resistance, in which free fatty acids provide a compensatory fuel for repressed glucose uptake.
“Likewise, FAO is activated in insulin resistance, in which free fatty acids provide a compensatory fuel for repressed glucose uptake.62,63”
From The multifaceted contributions of mitochondria to cellular metabolism (2018) · cites this paper as [63]
Cites
Positional cloning of the mouse obese gene and its human homologue
Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., & Friedman, J. M. (1994) · Nature · doi:10.1038/372425a0 · Cited by 13,419 · see citing works
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · see citing works
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207 · see citing works
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
Bedard, K., & Krause, K.-H. (2007) · Physiological Reviews · doi:10.1152/physrev.00044.2005 · Cited by 6,989 · see citing works
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433 · see citing works
Hydroperoxide metabolism in mammalian organs.
Chance, B., Sies, H., & Boveris, A. (1979) · Physiological Reviews · doi:10.1152/physrev.1979.59.3.527 · Cited by 5,827 · see citing works
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652 · see citing works
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · see citing works
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810 · see citing works
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769 · see citing works
Obesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · see citing works
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399 · see citing works
Steatohepatitis: A tale of two “hits”?
Day, C. P., & James, O. F. W. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70599-2 · Cited by 4,285 · see citing works
Endoplasmic Reticulum Stress Links Obesity, Insulin Action, and Type 2 Diabetes
Özcan, U., Cao, Q., Yilmaz, E., Lee, A.-H., Iwakoshi, N. N., Özdelen, E., Tuncman, G., Görgün, C., Glimcher, L. H., & Hotamisligil, G. S. (2004) · Science · doi:10.1126/science.1103160 · Cited by 3,844 · see citing works
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604 · see citing works
Cold-Activated Brown Adipose Tissue in Healthy Men
van Marken Lichtenbelt, W. D., Vanhommerig, J. W., Smulders, N. M., Drossaerts, J. M. A. F. L., Kemerink, G. J., Bouvy, N. D., Schrauwen, P., & Teule, G. J. J. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808718 · Cited by 3,452 · see citing works
AMPK regulates energy expenditure by modulating NAD+ metabolism and SIRT1 activity
Cantó, C., Gerhart-Hines, Z., Feige, J. N., Lagouge, M., Noriega, L., Milne, J. C., Elliott, P. J., Puigserver, P., & Auwerx, J. (2009) · Nature · doi:10.1038/nature07813 · Cited by 3,300 · see citing works
Functional Brown Adipose Tissue in Healthy Adults
Virtanen, K. A., Lidell, M. E., Orava, J., Heglind, M., Westergren, R., Niemi, T., Taittonen, M., Laine, J., Savisto, N.-J., Enerbäck, S., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808949 · Cited by 3,058 · see citing works
Endoplasmic reticulum stress and the inflammatory basis of metabolic disease
Hotamisligil, G. S. (2010) · Cell · doi:10.1016/j.cell.2010.02.034 · Cited by 2,802 · see citing works
Macrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733 · see citing works
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525 · see citing works
Mechanisms for Insulin Resistance: Common Threads and Missing Links
Samuel, V. T., & Shulman, G. I. (2012) · Cell · doi:10.1016/j.cell.2012.02.017 · Cited by 2,294 · see citing works
Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes.
Guilherme, A., Virbasius, J. V., Puri, V., & Czech, M. P. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2391 · Cited by 2,292 · see citing works
Adipocytes as regulators of energy balance and glucose homeostasis
Rosen, E. D., & Spiegelman, B. M. (2006) · Nature · doi:10.1038/nature05483 · Cited by 2,170 · cited 1× · see citing works
“WAT has long been recognized as the main storage site for lipids derived from food intake (142).”
Human Fatty Liver Disease: Old Questions and New Insights
Cohen, J. C., Horton, J. D., & Hobbs, H. H. (2011) · Science · doi:10.1126/science.1204265 · Cited by 2,089 · see citing works
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070 · see citing works
Koves, T. R., Ussher, J. R., Noland, R. C., Slentz, D., Mosedale, M., Ilkayeva, O., Bain, J., Stevens, R., Dyck, J. R. B., Newgard, C. B., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.013 · Cited by 1,990 · see citing works
Hatori, M., Vollmers, C., Zarrinpar, A., DiTacchio, L., Bushong, E. A., Gill, S., Leblanc, M., Chaix, A., Joens, M., Fitzpatrick, J. A. J., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.019 · Cited by 1,986 · see citing works
Adipose tissue remodeling and obesity
Sun, K., Kusminski, C. M., & Scherer, P. E. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45887 · Cited by 1,941 · see citing works
High Incidence of Metabolically Active Brown Adipose Tissue in Healthy Adult Humans
Saito, M., Okamatsu-Ogura, Y., Matsushita, M., Watanabe, K., Yoneshiro, T., Nio-Kobayashi, J., Iwanaga, T., Miyagawa, M., Kameya, T., Nakada, K., et al. (2009) · Diabetes · doi:10.2337/db09-0530 · Cited by 1,848 · see citing works
Unexpected evidence for active brown adipose tissue in adult humans
Nedergaard, J., Bengtsson, T., & Cannon, B. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00691.2006 · Cited by 1,824 · see citing works
Obesity, Inflammation, and Insulin Resistance
Shoelson, S. E., Herrero, L., & Naaz, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.059 · Cited by 1,806 · see citing works
Self-citationDeFronzo, R. A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., & Felber, J. P. (1981) · Diabetes · doi:10.2337/diab.30.12.1000 · Cited by 1,770 · see citing works
Free radicals and tissue damage produced by exercise
Davies, K. J. A., Quintanilha, A. T., Brooks, G. A., & Packer, L. (1982) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(82)80124-1 · Cited by 1,739 · see citing works
Sirtuins in mammals: insights into their biological function
Michán, S., & Sinclair, D. A. (2007) · Biochemical Journal · doi:10.1042/bj20070140 · Cited by 1,719 · see citing works
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
Woods, A., Johnstone, S. R., Dickerson, K., Leiper, F. C., Fryer, L. G. D., Neumann, D., Schlattner, U., Wallimann, T., Carlson, M., & Carling, D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.031 · Cited by 1,650 · see citing works
AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus
Minokoshi, Y., Alquier, T., Furukawa, N., Kim, Y.-B., Lee, A., Xue, B., Mu, J., Foufelle, F., Ferré, P., Birnbaum, M. J., et al. (2004) · Nature · doi:10.1038/nature02440 · Cited by 1,637 · see citing works
The Mitochondrial Carnitine Palmitoyltransferase System — From Concept to Molecular Analysis
McGarry, J. D., & Brown, N. F. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00001.x · Cited by 1,616 · cited 16× · see citing works
“(B) Enhancing FAO by the over-expression of CPT1AM (117, 130) increases the production of ketone bodies, ATP, and CO 2 .”
InfluentialAdipose tissue as an endocrine organ
Galić, S., Oakhill, J. S., & Steinberg, G. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.018 · Cited by 1,597 · see citing works
Developmental Origin of Fat: Tracking Obesity to Its Source
Gesta, S., Tseng, Y.-H., & Kahn, C. R. (2007) · Cell · doi:10.1016/j.cell.2007.10.004 · Cited by 1,508 · see citing works
Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese
Enerbäck, S., Jacobsson, A., Simpson, E. M., Guerra, C., Yamashita, H., Harper, M.-E., & Kozak, L. P. (1997) · Nature · doi:10.1038/387090a0 · Cited by 1,379 · see citing works
Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma: A Weighty Connection
Starley, B. Q., Calcagno, C. J., & Harrison, S. A. (2010) · Hepatology · doi:10.1002/hep.23594 · Cited by 1,340 · see citing works
Feldmann, H. M., Golozoubova, V., Cannon, B., & Nedergaard, J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2008.12.014 · Cited by 1,318 · see citing works
Adipose Tissue Hypoxia in Obesity and Its Impact on Adipocytokine Dysregulation
Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y., Tanaka, S., Segawa, K., Furukawa, S., Tochino, Y., Komuro, R., Matsuda, M., et al. (2007) · Diabetes · doi:10.2337/db06-0911 · Cited by 1,257 · cited 2× · see citing works
“The excessive accumulation of lipids in the adipose tissue leads to adipocyte hypoxia (73), endoplasmic reticulum (ER) stress (132), and cell death, and causes FA spillover (145).”
Maximal perfusion of skeletal muscle in man.
Andersen, P., & Saltin, B. (1985) · The Journal of Physiology · doi:10.1113/jphysiol.1985.sp015794 · Cited by 1,250 · see citing works
Shulman, G. I., Rothman, D. L., Jue, T., Stein, P., DeFronzo, R. A., & Shulman, R. G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001253220403 · Cited by 1,248 · see citing works
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · see citing works
Lipid-induced insulin resistance: unravelling the mechanism
Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60408-4 · Cited by 1,189 · see citing works
Alternatively activated macrophages produce catecholamines to sustain adaptive thermogenesis
Nguyen, K. D., Qiu, Y., Cui, X., Goh, Y. P. S., Mwangi, J., David, T., Mukundan, L., Brombacher, F., Locksley, R. M., & Chawla, A. (2011) · Nature · doi:10.1038/nature10653 · Cited by 1,038 · see citing works
Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome — An allostatic perspective
Virtue, S., & Vidal-Puig, A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.12.006 · Cited by 1,013 · see citing works
Regulation of Hepatic Lipogenesis by the Transcription Factor XBP1
Lee, A., Scapa, E. F., Cohen, D. E., & Glimcher, L. H. (2008) · Science · doi:10.1126/science.1158042 · Cited by 978 · see citing works
Keller, H., Dreyer, C., Medin, J. A., Mahfoudi, A., Ozato, K., & Wahli, W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.6.2160 · Cited by 948 · see citing works
Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G., Dessì-Fulgheri, P., Zhang, C., Takahashi, N., Sarzani, R., & Collins, S. (2012) · Journal of Clinical Investigation · doi:10.1172/jci59701 · Cited by 872 · see citing works
Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis
Tiniakos, D. G., Vos, M. B., & Brunt, E. M. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-121808-102132 · Cited by 870 · see citing works
Gomez-Cabrera, M.-C., Domenech, E., Romagnoli, M., Arduini, A., Borras, C., Pallardo, F. V., Sastre, J., & Viña, J. (2008) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/87.1.142 · Cited by 844 · see citing works
SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825 · see citing works
Hirschey, M. D., Shimazu, T., Jing, E., Grueter, C. A., Collins, A. M., Aouizerat, B., Stančáková, A., Goetzman, E., Lam, M. M., Schwer, B., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.07.019 · Cited by 787 · see citing works
Circadian rhythms, sleep, and metabolism
Huang, W., Ramsey, K. M., Marcheva, B., & Bass, J. T. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46043 · Cited by 726 · see citing works
Zingaretti, M. C., Crosta, F., Vitali, A., Guerrieri, M., Frontini, A., Cannon, B., Nedergaard, J., & Cinti, S. (2009) · The FASEB Journal · doi:10.1096/fj.09-133546 · Cited by 725 · see citing works
UCP2 mediates ghrelin’s action on NPY/AgRP neurons by lowering free radicals
Andrews, Z. B., Liu, Z.-W., Walllingford, N., Erion, D. M., Borok, E., Friedman, J. M., Tschöp, M. H., Shanabrough, M., Cline, G., Shulman, G. I., et al. (2008) · Nature · doi:10.1038/nature07181 · Cited by 710 · see citing works
Endoplasmic reticulum stress, obesity and diabetes
Cnop, M., Foufelle, F., & Velloso, L. A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.07.010 · Cited by 683 · see citing works
Sunny, N. E., Parks, E. J., Browning, J. D., & Burgess, S. C. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.11.004 · Cited by 672 · see citing works
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665 · see citing works
Central Administration of Oleic Acid Inhibits Glucose Production and Food Intake
Obici, S., Feng, Z., Morgan, K., Stein, D., Karkanias, G., & Rossetti, L. (2002) · Diabetes · doi:10.2337/diabetes.51.2.271 · Cited by 654 · see citing works
Oxidative stress and the etiology of insulin resistance and type 2 diabetes
Henriksen, E. J., Diamond-Stanic, M. K., & Marchionne, E. M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.12.005 · Cited by 600 · see citing works
Adams, S. H., Hoppel, C. L., Lok, K. H., Zhao, L., Wong, S. W., Minkler, P. E., Hwang, D. H., Newman, J. W., & Garvey, W. T. (2009) · The Journal of Nutrition · doi:10.3945/jn.108.103754 · Cited by 598 · see citing works
Cellular bioenergetics as a target for obesity therapy
Tseng, Y.-H., Cypess, A. M., & Kahn, C. R. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3138 · Cited by 591 · see citing works
Gregor, M. F., & Hotamisligil, G. S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700007-jlr200 · Cited by 586 · see citing works
Reactive oxygen species enhance insulin sensitivity
Loh, K., Deng, H., Fukushima, A., Cai, X., Boivin, B., Galic, S., Bruce, C., Shields, B. J., Skiba, B., Ooms, L. M., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.08.009 · Cited by 581 · see citing works
BMP8B Increases Brown Adipose Tissue Thermogenesis through Both Central and Peripheral Actions
Whittle, A. J., Carobbio, S., Martins, L., Slawik, M., Hondares, E., Vázquez, M. J., Morgan, D., Csikasz, R. I., Gallego, R., Rodriguez-Cuenca, S., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.066 · Cited by 573 · see citing works
Kopecky, J., Clarke, G., Enerbäck, S., Spiegelman, B., & Kozak, L. P. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118363 · Cited by 553 · see citing works
Obici, S., Feng, Z., Arduini, A., Conti, R., & Rossetti, L. (2003) · Nature Medicine · doi:10.1038/nm873 · Cited by 548 · see citing works
“New” hepatic fat activates PPARα to maintain glucose, lipid, and cholesterol homeostasis
Chakravarthy, M. V., Pan, Z., Zhu, Y., Tordjman, K. M., Schneider, J. G., Coleman, T., TURK, J. W., & Semenkovich, C. F. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.04.002 · Cited by 545 · see citing works
Positive and Negative Regulation of Insulin Signaling by Reactive Oxygen and Nitrogen Species
Bashan, N., Kovsan, J., Kachko, I., Ovadia, H., & Rudich, A. (2009) · Physiological Reviews · doi:10.1152/physrev.00014.2008 · Cited by 542 · see citing works
Uncoupling proteins and the control of mitochondrial reactive oxygen species production
Mailloux, R. J., & Harper, M. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.06.022 · Cited by 534 · see citing works
Identification of a Physiologically Relevant Endogenous Ligand for PPARα in Liver
Chakravarthy, M. V., Lodhi, I. J., Yin, L., Malapaka, R. R. V., Xu, H. E., TURK, J. W., & Semenkovich, C. F. (2009) · Cell · doi:10.1016/j.cell.2009.05.036 · Cited by 534 · see citing works
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease
Kohjima, M., Enjoji, M., Higuchi, N., Kato, M., Kotoh, K., Yoshimoto, T., Fujino, T., Yada, M., Yada, R., Harada, N., et al. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.3.351 · Cited by 530 · see citing works
O'Neil, P. M., Smith, S. R., Weissman, N. J., Fidler, M. C., Sanchez, M., Zhang, J., Raether, B., Anderson, C. M., & Shanahan, W. R. (2012) · Obesity · doi:10.1038/oby.2012.66 · Cited by 528 · see citing works
Immunometabolism: an emerging frontier
Mathis, D. J., & Shoelson, S. E. (2011) · Nature reviews. Immunology · doi:10.1038/nri2922 · Cited by 522 · see citing works
Excess Lipid Availability Increases Mitochondrial Fatty Acid Oxidative Capacity in Muscle
Turner, N., Bruce, C. R., Beale, S. M., Hoehn, K. L., So, T., Rolph, M. S., & Cooney, G. J. (2007) · Diabetes · doi:10.2337/db07-0093 · Cited by 520 · see citing works
Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle
Boushel, R., Gnaiger, E., Schjerling, P., Skovbro, M., Kraunsøe, R., & Dela, F. (2007) · Diabetologia · doi:10.1007/s00125-007-0594-3 · Cited by 519 · see citing works
Simoneau, J., Veerkamp, J. H., Turcotte, L. P., & Kelley, D. E. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.14.2051 · Cited by 491 · see citing works
Hypothalamic sensing of fatty acids
Lam, T. K. T., Schwartz, G. J., & Rossetti, L. (2005) · Nature Neuroscience · doi:10.1038/nn1456 · Cited by 478 · see citing works
Jing, E., Emanuelli, B., Hirschey, M. D., Boucher, J., Lee, K. Y., Lombard, D., Verdin, E. M., & Kahn, C. R. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111308108 · Cited by 469 · see citing works
An, J., Muoio, D. M., Shiota, M., Fujimoto, Y., Cline, G. W., Shulman, G. I., Koves, T. R., Stevens, R., Millington, D., & Newgard, C. B. (2004) · Nature Medicine · doi:10.1038/nm995 · Cited by 450 · see citing works
Savage, D. B. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27300 · Cited by 447 · see citing works
Heffetz, D., Bushkin, I., Dror, R., & Zick, Y. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39885-0 · Cited by 429 · see citing works
Paterson, J. M., Morton, N. M., Fiévet, C., Kenyon, C. J., Holmes, M. C., Staels, B., Seckl, J. R., & Mullins, J. J. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305524101 · Cited by 427 · see citing works
Pillai, V. B., Sundaresan, N. R., Kim, G. H., Gupta, M., Rajamohan, S. B., Pillai, J. B., Samant, S. A., Ravindra, P. A., Isbatan, A., & Gupta, M. P. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.077271 · Cited by 420 · see citing works
Abu-Elheiga, L., Oh, W., Kordari, P., & Wakil, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1733877100 · Cited by 389 · see citing works
Autophagy in Hypothalamic AgRP Neurons Regulates Food Intake and Energy Balance
Kaushik, S., Rodriguez-Navarro, J. A., Arias, E., Kiffin, R., Sahu, S., Schwartz, G. J., Cuervo, A. M., & Singh, R. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.008 · Cited by 382 · see citing works
Hondares, E., Rosell, M., Gonzalez, F. J., Giralt, M., Iglesias, R., & Villarroya, F. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.001 · Cited by 377 · see citing works
Wagner, B. A., Buettner, G. R., & Burns, C. P. (1994) · Biochemistry · doi:10.1021/bi00181a003 · Cited by 367 · see citing works
Sixteen years and counting: an update on leptin in energy balance
Gautron, L., & Elmquist, J. K. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45888 · Cited by 367 · see citing works
Nuclear receptor corepressor RIP140 regulates fat accumulation
Leonardsson, G., Steel, J. H., Christian, M., Pocock, V., Milligan, S., Bell, J., So, P.-W., Medina-Gomez, G., Vidal-Puig, A., White, R., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401013101 · Cited by 366 · see citing works
Bruce, C. R., Hoy, A. J., Turner, N., Watt, M. J., Allen, T. L., Carpenter, K., Cooney, G. J., Febbraio, M. A., & Kraegen, E. W. (2009) · Diabetes · doi:10.2337/db08-1078 · Cited by 363 · see citing works
Irrcher, I., Ljubicic, V., & Hood, D. A. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00267.2007 · Cited by 356 · see citing works
JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction
Solinas, G., & Karin, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-151340 · Cited by 347 · see citing works
Neurobiology of Feeding and Energy Expenditure
Gao, Q., & Horvath, T. L. (2007) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094324 · Cited by 346 · see citing works
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Muoio, D. M., & Neufer, P. D. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.010 · Cited by 343 · see citing works
Bruce, C. R., Thrush, A. B., Mertz, V. A., Bezaire, V., Chabowski, A., Heigenhauser, G. J. F., & Dyck, D. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00587.2005 · Cited by 328 · see citing works
Choi, C. S., Savage, D. B., Abu-Elheiga, L., Liu, Z.-X., Kim, S., Kulkarni, A., Distefano, A., Hwang, Y.-J., Reznick, R. M., Codella, R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706794104 · Cited by 325 · see citing works
Sirtuin 1 in lipid metabolism and obesity
Schug, T. T., & Li, X. (2011) · Annals of Medicine · doi:10.3109/07853890.2010.547211 · Cited by 292 · see citing works
Exercise training increases lipid metabolism gene expression in human skeletal muscle
Tunstall, R. J., Mehan, K. A., Wadley, G. D., Collier, G. R., Bonen, A., Hargreaves, M., & Cameron-Smith, D. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00475.2001 · Cited by 292 · see citing works
Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells.
Pizer, E. S., Jackisch, C., Wood, F. D., Pasternack, G. R., Davidson, N. E., & Kuhajda, F. P. (1996) · PubMed · Cited by 291 · see citing works
Iglesias, M. A., Ye, J.-M., Frangioudakis, G., Saha, A. K., Tomas, E., Ruderman, N. B., Cooney, G. J., & Kraegen, E. W. (2002) · Diabetes · doi:10.2337/diabetes.51.10.2886 · Cited by 290 · see citing works
Ritov, V. B., Menshikova, E. V., Azuma, K., Wood, R., Toledo, F. G. S., Goodpaster, B. H., Ruderman, N. B., & Kelley, D. E. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00317.2009 · Cited by 283 · see citing works
A Novel Brain-Expressed Protein Related to Carnitine Palmitoyltransferase I
Price, N. T., van der Leij, F. R., Jackson, V. N., Corstorphine, C. G., Thomson, R., Sørensen, A., & Zammit, V. A. (2002) · Genomics · doi:10.1006/geno.2002.6845 · Cited by 270 · see citing works
The ins and outs of mitochondrial dysfunction in NASH
Fromenty, B., Robin, M., Igoudjil, A., Mansouri, A., & Pessayre, D. (2004) · Diabetes & Metabolism · doi:10.1016/s1262-3636(07)70098-8 · Cited by 266 · see citing works
Harwood, H. J., Petras, S. F., Shelly, L. D., Zaccaro, L. M., Perry, D. A., Makowski, M. R., Hargrove, D. M., Martin, K. A., Tracey, W. R., Chapman, J. G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304481200 · Cited by 242 · see citing works
Esser, V., Britton, C. H., Weis, B. C., Foster, D. W., & McGarry, J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53392-5 · Cited by 219 · see citing works
ATF6 modulates SREBP2‐mediated lipogenesis
Zeng, L., Lu, M. M., Mori, K., Luo, S. D., Lee, A. S., Zhu, Y., & Shyy, J. Y. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600106 · Cited by 218 · see citing works
Leptin activates hypothalamic acetyl-CoA carboxylase to inhibit food intake
Gao, S., Kinzig, K. P., Aja, S., Scott, K. A., Keung, W., Kelly, S., Strynadka, K., Chohnan, S., Smith, W. W., Tamashiro, K. L. K., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708385104 · Cited by 215 · see citing works
Giralt, A., Hondares, E., Villena, J. A., Ribas, F., Díaz-Delfín, J., Giralt, M., Iglesias, R., & Villarroya, F. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.202390 · Cited by 210 · see citing works
UCP1 deficiency increases susceptibility to diet‐induced obesity with age
Kontani, Y., Wang, Y., Kimura, K., Inokuma, K. ‐., Saito, M., Suzuki‐Miura, T., Wang, Z., Sato, Y., Mori, N., & Yamashita, H. (2005) · Aging Cell · doi:10.1111/j.1474-9726.2005.00157.x · Cited by 207 · see citing works
A potent PPARα agonist stimulates mitochondrial fatty acid β-oxidation in liver and skeletal muscle
Minnich, A., Tian, N., Byan, L., & Bilder, G. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.280.2.e270 · Cited by 192 · see citing works
Han, C. Y., Umemoto, T., Omer, M., Den Hartigh, L. J., Chiba, T., LeBoeuf, R., Buller, C. L., Sweet, I. R., Pennathur, S., Abel, E. D., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.304998 · Cited by 187 · see citing works
Anti-obesity drugs: a review about their effects and their safety
Derosa, G., & Maffioli, P. (2012) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2012.675326 · Cited by 185 · see citing works
Ahima, R. S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58719 · Cited by 175 · see citing works
Barroso, E., Rodríguez‐Calvo, R., Serrano, L., Astudillo, A. M., Balsinde, J., Palomer, X., & Vázquez‐Carrera, M. (2011) · Endocrinology · doi:10.1210/en.2010-1468 · Cited by 162 · see citing works
The Central Sirtuin 1/p53 Pathway Is Essential for the Orexigenic Action of Ghrelin
Velásquez, D. A., Martínez, G., Romero, A., Vázquez, M. J., Boit, K. D., Dopeso-Reyes, I. G., López, M., Vidal, A., Nogueiras, R., & Diéguez, C. (2011) · Diabetes · doi:10.2337/db10-0802 · Cited by 161 · see citing works
Characteristics and mechanisms of hypothalamic neuronal fatty acid sensing
Le Foll, C., Irani, B. G., Magnan, C., Dunn-Meynell, A. A., & Levin, B. E. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00223.2009 · Cited by 159 · cited 2× · see citing works
“Nonetheless, the direct correlation observed between fasting and FFA levels (156) and the capacity of hypothalamic neurons to sense glucose and FFA simultaneously and to integrate other nutritional and hormonal inputs (95, 99) seem to throw light on how important FAO really is in hypothalamic nuclei.”
Henique, C., Mansouri, A., Fumey, G., Lenoir, V., Girard, J., Bouillaud, F., Prip-Buus, C., & Cohen, I. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.170431 · Cited by 159 · see citing works
Lumeng, C. N.-K., Maillard, I. P., & Saltiel, A. R. (2009) · Nature Medicine · doi:10.1038/nm0809-846 · Cited by 158 · see citing works
Inflammation and adipose tissue macrophages in lipodystrophic mice
Herrero, L., Shapiro, H., Nayer, A., Lee, J., & Shoelson, S. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905310107 · Cited by 158 · see citing works
Self-citationRole of insulin receptor phosphorylation in the insulinomimetic effects of hydrogen peroxide.
Hayes, G. R., & Lockwood, D. H. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.22.8115 · Cited by 155 · see citing works
Louet, J., Chatelain, F., Decaux, J., Park, E. A., Kohl, C., Pineau, T., Girard, J. R., & Pégorier, J. P. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3540189 · Cited by 154 · see citing works
Yeh, L.-A., Lee, K. H., & Kim, K. H. (1980) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85891-x · Cited by 153 · see citing works
Gambino, R., Musso, G., & Cassader, M. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.3058 · Cited by 146 · see citing works
Miele, L., Grieco, A., Armuzzi, A., Candelli, M., Forgione, A., Gasbarrini, A., & Gasbarrini, A. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07725.x · Cited by 142 · see citing works
Higaki, Y., Mikami, T., Fujii, N., Hirshman, M. F., Koyama, K., Seino, T., Tanaka, K., & Goodyear, L. J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00150.2007 · Cited by 138 · see citing works
Intramuscular triacylglycerol and insulin resistance: guilty as charged or wrongly accused?
Muoio, D. M. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.11.007 · Cited by 137 · see citing works
Orellana-Gavaldà, J. M., Herrero, L., Malandrino, M. I., Pañeda, A., Sol Rodríguez-Peña, M., Petry, H., Asins, G., Van Deventer, S., Hegardt, F. G., & Serra, D. (2011) · Hepatology · doi:10.1002/hep.24140 · Cited by 135 · see citing works
Self-citationMechanism responsible for 5-(tetradecyloxy)-2-furoic acid inhibition of hepatic lipogenesis.
McCune, S. A., & Harris, R. A. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86677-2 · Cited by 133 · see citing works
Cook, G. A., & Gamble, M. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61616-3 · Cited by 131 · see citing works
Forkhead Box O as a Sensor, Mediator, and Regulator of Redox Signaling
de Keizer, P. L. J., Burgering, B. M. T., & Dansen, T. B. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3403 · Cited by 131 · see citing works
Muoio, D. M., & Koves, T. R. (2007) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h07-083 · Cited by 129 · see citing works
Serviddio, G., Giudetti, A. M., Bellanti, F., Priore, P., Rollo, T., Tamborra, R., Siculella, L., Vendemiale, G., Altomare, E., & Gnoni, G. V. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024084 · Cited by 128 · see citing works
Regulation of hypothalamic malonyl-CoA by central glucose and leptin
Wolfgang, M. J., Cha, S. H., Sidhaye, A., Chohnan, S., Cline, G., Shulman, G. I., & Lane, M. D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709778104 · Cited by 127 · see citing works
Yamazaki, N., Shinohara, Y., Shima, A., & Terada, H. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00277-g · Cited by 125 · see citing works
Chatelain, F., Kohl, C., Esser, V., Mcgarry, J. D., Girard, J., & Pegorier, J. (1996) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1996.00789.x · Cited by 123 · see citing works
Lage, R., Vázquez, M. J., Varela, L., Saha, A. K., Vidal‐Puig, A., Nogueiras, R., Diéguez, C., & López, M. (2010) · The FASEB Journal · doi:10.1096/fj.09-150672 · Cited by 123 · see citing works
Therapeutic Approaches to Target Inflammation in Type 2 Diabetes
Goldfine, A. B., Fonseca, V. A., & Shoelson, S. E. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.148833 · Cited by 116 · see citing works
Liver fat and lipid oxidation in humans
Kotronen, A., Seppälä‐Lindroos, A., Vehkavaara, S., Bergholm, R., Frayn, K. N., Fielding, B. A., & Yki‐Järvinen, H. (2009) · Liver International · doi:10.1111/j.1478-3231.2009.02076.x · Cited by 115 · see citing works
Velasco, G., Geelen, M. J. H., & Guzmán, M. (1997) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.9784 · Cited by 115 · see citing works
Iglesias, P., Selgas, R., Romero, S., & Díez, J. J. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0357 · Cited by 113 · see citing works
DRYNAN, L., QUANT, P. A., & ZAMMIT, V. A. (1996) · Biochemical Journal · doi:10.1042/bj3170791 · Cited by 107 · see citing works
Park, E. A., Mynatt, R. L., Cook, G. A., & Kashfi, K. (1995) · Biochemical Journal · doi:10.1042/bj3100853 · Cited by 105 · see citing works
Ins and Outs Modulating Hepatic Triglyceride and Development of Nonalcoholic Fatty Liver Disease
Goldberg, I. J., & Ginsberg, H. N. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.040 · Cited by 99 · see citing works
Conti, R., Mannucci, E., Pessotto, P., Tassoni, E., Carminati, P., Giannessi, F., & Arduini, A. (2011) · Diabetes · doi:10.2337/db10-0346 · Cited by 98 · see citing works
Brady, L. J., Brady, P. S., Romsos, D. R., & Hoppel, C. L. (1985) · Biochemical Journal · doi:10.1042/bj2310439 · Cited by 92 · see citing works
Monsénégo, J., Mansouri, A., Akkaoui, M., Lenoir, V., Esnous, C., Fauveau, V., Tavernier, V., Girard, J., & Prip-Buus, C. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.10.008 · Cited by 91 · see citing works
Taubes, G. (2009) · Science · doi:10.1126/science.325_256 · Cited by 91 · see citing works
CPT I overexpression protects L6E9 muscle cells from fatty acid-induced insulin resistance
Sebastián, D., Herrero, L., Serra, D., Asins, G., & Hegardt, F. G. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00360.2006 · Cited by 89 · see citing works
Self-citationKudin, A. P., Malinska, D., & Kunz, W. S. (2008) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2008.05.010 · Cited by 84 · see citing works
Chen, M.-T., Kaufman, L. N., Spennetta, T., & Shrago, E. (1992) · Metabolism · doi:10.1016/0026-0495(92)90221-u · Cited by 83 · see citing works
Lipid Sensing and Insulin Resistance in the Brain
Yue, J. T. Y., & Lam, T. K. T. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.013 · Cited by 82 · see citing works
Ortega, F. J., Jílková, Z. M., Moreno-Navarrete, J. M., Pavelka, S., Rodriguez-Hermosa, J. I., Kopeckỳ, J., & Fernández-Real, J. M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.101 · Cited by 80 · see citing works
Levin, B. E. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00763-1 · Cited by 79 · see citing works
Oxidant stress and skeletal muscle glucose transport: Roles of insulin signaling and p38 MAPK
Kim, J. S., Saengsirisuwan, V., Sloniger, J. A., Teachey, M. K., & Henriksen, E. J. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.05.031 · Cited by 78 · see citing works
Čiapaitė, J., van den Broek, N. M. A., Brinke, H. T., Nicolay, K., Jeneson, J. A. L., Houten, S. M., & Prompers, J. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.005 · Cited by 77 · see citing works
Giannessi, F., Pessotto, P., Tassoni, E., Chiodi, P., Conti, R., Angelis, F. D., Dell’Uomo, N., Catini, R., Deias, R., Tinti, M. O., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020979u · Cited by 74 · see citing works
Machann, J., Bachmann, O. P., Brechtel, K., Dahl, D. B., Wietek, B., Klumpp, B., Häring, H., Claussen, C. D., Jacob, S., & Schick, F. (2003) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.10255 · Cited by 73 · see citing works
Morillas, M., Gómez‐Puertas, P., Bentebibel, A., Sellés, E., Casals, N., Valencia, A., Hegardt, F. G., Asins, G., & Serra, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209999200 · Cited by 72 · see citing works
Self-citationRoman, E. A. F. R., Reis, D., Romanatto, T., Maimoni, D., Ferreira, E. A., Santos, G. A., Torsoni, A. S., Velloso, L. A., & Torsoni, M. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.007 · Cited by 71 · see citing works
Dyck, J. R. B., Berthiaume, L. G., Thomas, P. D., Kantor, P. F., Barr, A., Barr, R. L., Singh, D., Hopkins, T. A., Voilley, N., Prentki, M., et al. (2000) · Biochemical Journal · doi:10.1042/bj3500599 · Cited by 69 · see citing works
Gao, X., Li, K., Hui, X., Kong, X., Sweeney, G., Wang, Y., Xu, A., Teng, M., Liu, P., & Wu, D. (2011) · Biochemical Journal · doi:10.1042/bj20101680 · Cited by 68 · see citing works
Modulation of glucose transport in skeletal muscle by reactive oxygen species
Katz, A. (2007) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01066.2006 · Cited by 65 · see citing works
Brain lipid sensing and nervous control of energy balance
Migrenne, S., Le Foll, C., Levin, B. E., & Magnan, C. (2011) · Diabetes & Metabolism · doi:10.1016/j.diabet.2010.11.001 · Cited by 58 · see citing works
Novel Effect of C75 on Carnitine Palmitoyltransferase I Activity and Palmitate Oxidation
Bentebibel, A., Sebastián, D., Herrero, L., López-Viñas, E., Serra, D., Asins, G., Gómez-Puertas, P., & Hegardt, F. G. (2006) · Biochemistry · doi:10.1021/bi052186q · Cited by 58 · see citing works
Self-citationMera, P., Bentebibel, A., López-Viñas, E., Cordente, A. G., Gurunathan, C., Sebastián, D., Vázquez, I., Herrero, L., Ariza, X., Gómez-Puertas, P., et al. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.11.020 · Cited by 57 · see citing works
Self-citationChapter 8 Acetylation of Mitochondrial Proteins
Hirschey, M. D., Shimazu, T., Huang, J., & Verdin, E. (2009) · Methods in Enzymology · doi:10.1016/s0076-6879(09)05008-3 · Cited by 55 · see citing works
Denu, J. M., & Tanner, K. G. (2002) · Methods in Enzymology · doi:10.1016/s0076-6879(02)48648-x · Cited by 50 · see citing works
Han, D.-H., Nolte, L. A., Ju, J.-S., Coleman, T., Holloszy, J. O., & Semenkovich, C. F. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00434.2003 · Cited by 49 · see citing works
GH Does Not Modulate the Early Fasting-Induced Release of Free Fatty Acids in Mice
Steyn, F. J., Leong, J. W., Huang, L., Tan, H. Y., Xie, T. Y., Nelson, C., Waters, M. J., Veldhuis, J. D., Epelbaum, J., & Chen, C. (2012) · Endocrinology · doi:10.1210/en.2011-1681 · Cited by 44 · see citing works
Kuo, D.-Y., Chen, P.-N., Yang, S.-F., Chu, S.-C., Chen, C.-H., Kuo, M.-H., Yu, C.-H., & Hsieh, Y.-S. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3738 · Cited by 41 · see citing works
Role of lipid-derived mediators in skeletal muscle insulin resistance
Taube, A., Eckardt, K., & Eckel, J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00241.2009 · Cited by 40 · see citing works
May, C. L., Caüzac, M., Diradourian, C., Perdereau, D., Girard, J. R., Burnol, A., & Pégorier, J. P. (2005) · Journal of Nutrition · doi:10.1093/jn/135.10.2313 · Cited by 35 · see citing works
Current Updates in the Medical Management of Obesity
Khan, A. U., Raza, S., Khan, Y., Aksoy, T., Khan, M., Weinberger, Y., & Goldman, J. M. (2012) · Recent Patents on Endocrine Metabolic & Immune Drug Discovery · doi:10.2174/187221412800604644 · Cited by 25 · see citing works
Mollica, M. P., Iossa, S., Liverini, G., & Soboll, S. (1998) · Molecular and Cellular Biochemistry · doi:10.1023/a:1006899632413 · Cited by 21 · see citing works
More than satiety: central serotonin signaling and glucose homeostasis.
Pissios, P., & Maratos-Flier, E. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.10.009 · Cited by 20 · see citing works
Setting the Tone: Reactive Oxygen Species and the Control of Appetitive Melanocortin Neurons
Rochford, J. J., Myers, M. G., & Heisler, L. K. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.10.004 · Cited by 5 · see citing works
Flagged first, then by citations
Research works printed but not linked: 3
- Khan A, 2012, Recent Pat Endocr Metab, 6, 117
- Nakamuta M, 2005, Int J Mol Med, 16, 631
- Pizer ES, 1996, Cancer Res, 56, 2745
Cited by
Sorted by citations
The multifaceted contributions of mitochondria to cellular metabolism
Spinelli, J. B., & Haigis, M. C. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0124-1 · Cited by 1,935 · see citing works
Manna, P., & Jain, S. K. (2015) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2015.0095 · Cited by 1,167 · see citing works
Mitochondrial and metabolic dysfunction in ageing and age-related diseases
Amorim, J. A., Coppotelli, G., Rolo, A. P., Palmeira, C. M., Ross, J. M., & Sinclair, D. A. (2022) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00626-7 · Cited by 990 · see citing works
Obesity-Associated Oxidative Stress: Strategies Finalized to Improve Redox State
Savini, I., Catani, M. V., Evangelista, D., Gasperi, V., & Avigliano, L. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510497 · Cited by 514 · see citing works
Oxidative Stress, Plant Natural Antioxidants, and Obesity
Pérez-Torres, I., Castrejón-Téllez, V., Soto, M. E., Rubio-Ruiz, M. E., Manzano-Pech, L., & Guarner‐Lans, V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041786 · Cited by 411 · see citing works
Collins, K. H., Herzog, W., MacDonald, G. Z., Reimer, R. A., Rios, J. L., Smith, I. C. P., Zernicke, R. F., & Hart, D. A. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.00112 · Cited by 311 · see citing works
Regulation of obesity and insulin resistance by nitric oxide
Sansbury, B. E., & Hill, B. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.05.016 · Cited by 274 · see citing works
“Additionally, recent studies have identified secreted proteins that stimulate brown adipocyte thermogenesis and recruit brown (or beige) adipocytes to white adipose tissue [60,61].”
BackgroundFujiwara, N., Nakagawa, H., Enooku, K., Kudo, Y., Hayata, Y., Nakatsuka, T., Tanaka, Y., Tateishi, R., Hikiba, Y., Misumi, K., et al. (2018) · Gut · doi:10.1136/gutjnl-2017-315193 · Cited by 221 · see citing works
Mitochondria and Metabolic Homeostasis
Cheng, Z., & Ristow, M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5255 · Cited by 188 · see citing works
Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
Nakagawa, H., Hayata, Y., Kawamura, S., Yamada, T., Fujiwara, N., & Koike, K. (2018) · Cancers · doi:10.3390/cancers10110447 · Cited by 176 · see citing works
Ye, Z., Wang, S., Zhang, C., & Zhao, Y. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00617 · Cited by 173 · see citing works
Lipid Metabolism in Development and Progression of Hepatocellular Carcinoma
Sangineto, M., Villani, R., Cavallone, F., Romano, A. D., Loizzi, D., & Serviddio, G. (2020) · Cancers · doi:10.3390/cancers12061419 · Cited by 152 · see citing works
Obesity and COVID-19: Molecular Mechanisms Linking Both Pandemics
Ritter, A., Kreis, N., Louwen, F., & Yuan, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165793 · Cited by 142 · see citing works
Zhao, H., Zhao, Y., Li, T., Li, M., Li, J., Li, R., Liu, P., Yu, Y., & Qiao, J. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.05.013 · Cited by 134 · see citing works
Delivery of drugs and macromolecules to the mitochondria for cancer therapy
Lu, P., Bruno, B. J., Rabenau, M., & Lim, C. S. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.10.023 · Cited by 131 · see citing works
The Role of Lipid and Lipoprotein Metabolism in Non‐Alcoholic Fatty Liver Disease
Perla, F. M., Prelati, M., Lavorato, M., Visicchio, D., & Anania, C. (2017) · Children · doi:10.3390/children4060046 · Cited by 129 · see citing works
Nitric oxide and mitochondria in metabolic syndrome
Litvinova, L. S., Atochin, D. N., Fattakhov, N. S., Василенко, М., Затолокин, П. А., & Кириенкова, Е. В. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00020 · Cited by 127 · see citing works
Fatty acid metabolism and the basis of brown adipose tissue function
Calderón‐Domínguez, M., Mir, J. F., Fucho, R., Weber, M., Serra, D., & Herrero, L. (2015) · Adipocyte · doi:10.1080/21623945.2015.1122857 · Cited by 126 · see citing works
Self-citationCeramides and mitochondrial fatty acid oxidation in obesity
Fucho, R., Casals, N., Serra, D., & Herrero, L. (2016) · The FASEB Journal · doi:10.1096/fj.201601156r · Cited by 124 · see citing works
Self-citationThe Role of the Nrf2 Signaling in Obesity and Insulin Resistance
Li, S., Eguchi, N., Lau, H., & Ichii, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186973 · Cited by 116 · see citing works
Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond
Cheng, Z., Zheng, L., & Almeida, F. A. (2017) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2017.10.004 · Cited by 114 · see citing works
Mechanisms of obesity-induced metabolic and vascular dysfunctions
Caldwell, R. W. (2019) · Frontiers in bioscience · doi:10.2741/4758 · Cited by 112 · see citing works
Tan, S. K., Mahmud, I., Fontanesi, F., Puchowicz, M., Neumann, C. K. A., Griswold, A. J., Patel, R., Dispagna, M., Ahmed, H. H., Gonzalgo, M. L., et al. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-20-1453 · Cited by 101 · see citing works
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Smirne, C., Croce, E., Benedetto, D. D., Cantaluppi, V., Comi, C., Sainaghi, P. P., Minisini, R., Grossini, E., & Pirisi, M. (2022) · Livers · doi:10.3390/livers2010003 · Cited by 92 · see citing works
Butyrate: A potential mediator of obesity and microbiome via different mechanisms of actions
Güler, M. S., Arslan, S., Ağagündüz, D., Cerqua, I., Pagano, E., Canani, R. B., & Capasso, R. (2024) · Food Research International · doi:10.1016/j.foodres.2024.115420 · Cited by 87 · see citing works
Supruniuk, E., Mikłosz, A., & Chabowski, A. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00923 · Cited by 83 · see citing works
Gamboa‐Gómez, C. I., Simental‐Mendía, L. E., González‐Laredo, R. F., Alcantar-Orozco, E. D. J., Monserrat-Juarez, V. H., Ramírez-España, J. C., Gallegos‐Infante, J. A., Moreno‐Jiménez, M. R., & Rocha‐Guzmán, N. E. (2017) · Food Research International · doi:10.1016/j.foodres.2017.09.040 · Cited by 79 · see citing works
Obesity in Women: Insights for the Clinician
Tauqeer, Z., Gómez, G., & Stanford, F. C. (2017) · Journal of Women s Health · doi:10.1089/jwh.2016.6196 · Cited by 77 · see citing works
Butyrate and obesity: Current research status and future prospect
Peng, K., Dong, W., Luo, T., Tang, H., Zhu, W., Huang, Y., & Yang, X. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1098881 · Cited by 80 · see citing works
Johnson, R., de Beer, D., Dludla, P. V., Ferreira, D., Muller, C. J. F., & Joubert, E. (2018) · Planta Medica · doi:10.1055/s-0044-100622 · Cited by 76 · see citing works
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology
Barupal, D. K., Baillie, R., Fan, S., Saykin, A. J., Meikle, P. J., Arnold, M., Nho, K. T., Fiehn, O., Kaddurah-Daouk, R. F., & Initiative, A. D. N. (2019) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1016/j.dadm.2019.07.002 · Cited by 74 · see citing works
Shen, J., Yan, L., Liu, S., Ambrosone, C. B., & Zhao, H. (2013) · Translational Oncology · doi:10.1593/tlo.13619 · Cited by 72 · see citing works
Zielińska‐Bliźniewska, H., Sitarek, P., Merecz-Sadowska, A., Malinowska, K., Zajdel, K., Jabłońska, M. R., Śliwiński, T., & Zajdel, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184556 · Cited by 67 · see citing works
Stachowicz, A., Olszanecki, R., Suski, M., Wiśniewska, A., Totoń‐Żurańska, J., Madej, J., Jawień, J., Białas, M. B., Okoń, K., Gajda, M., et al. (2014) · Journal of the American Heart Association · doi:10.1161/jaha.114.001329 · Cited by 61 · see citing works
Role of mitochondria and mitochondria‐targeted agents in non‐alcoholic fatty liver disease
Ajith, T. A. (2017) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12886 · Cited by 60 · see citing works
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Montesdeoca, N., López, M., Ariza, X., Herrero, L., & Makowski, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000705r · Cited by 59 · see citing works
Self-citationUchinomiya, S., Matsunaga, N., Kamoda, K., Kawagoe, R., Tsuruta, A., Ohdo, S., & Ojida, A. (2020) · Chemical Communications · doi:10.1039/c9cc09993j · Cited by 59 · see citing works
Ding, Y., Xia, B., Zhang, C., & Zhuo, G. (2017) · PubMed Central · Cited by 58 · see citing works
Peleli, M., Ferreira, D. M. S., Tarnawski, L., Haworth, S. M., Xuechen, L., Zhuge, Z., Newton, P. T., Massart, J., Chagin, A. S., Olofsson, P. S., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101387 · Cited by 58 · see citing works
Mey, J. T., Erickson, M. L., Axelrod, C. L., King, W. T., Flask, C. A., McCullough, A. J., & Kirwan, J. P. (2020) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00058.2020 · Cited by 58 · see citing works
Wen, F., An, C., Wu, X., Yang, Y., Xu, J., Liu, Y., Wang, C., Nie, L., Fang, H., & Yang, Z. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.11.008 · Cited by 57 · see citing works
Bucher, M., Montaniel, K. R. C., Myatt, L., Weintraub, S. T., Tavori, H., & Maloyan, A. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420001026 · Cited by 53 · see citing works
Diabetes-induced hepatic oxidative stress: a new pathogenic role for glycated albumin
Patché, J., Girard, D., Catan, A., Boyer, F., Dobi, A., Planesse, C., Diotel, N., Guérin-Dubourg, A., Baret, P., Bravo, S. B., et al. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.11.026 · Cited by 52 · see citing works
Kaviani, S., & Cooper, J. A. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2016.250 · Cited by 52 · see citing works
Nyunt, T., Britton, M., Wanichthanarak, K., Budamagunta, M. S., Voss, J. C., Wilson, D. W., Rutledge, J. C., & Aung, H. H. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.07.024 · Cited by 51 · see citing works
Zhao, H., Zhao, Y., Ren, Y., Li, M., Li, T., Li, R., Yu, Y., & Qiao, J. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.10.039 · Cited by 51 · see citing works
El‐Sherbiny, M., Eldosoky, M., El‐Shafey, M., Othman, G., Elkattawy, H. A., Bedir, T., & Elsherbiny, N. M. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.04.010 · Cited by 50 · see citing works
Saeidi, A., Habashi, A. N., Razi, O., Ataeinosrat, A., Rahmani, H., Mollabashi, S. S., Bagherzadeh-Rahmani, B., Aghdam, S. M., Khalajzadeh, L., Kiyumi, M. H. A., et al. (2023) · Nutrients · doi:10.3390/nu15020286 · Cited by 49 · see citing works
Diaz, B., Fuentes‐Mera, L., Tovar, A. R., Montiel, T., Massieu, L., Martı́nez-Rodrı́guez, H. G., & Camacho‐Morales, A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.09.014 · Cited by 49 · see citing works
Hepatoprotection by dandelion ( Taraxacum officinale ) and mechanisms
Mahboubi, M., & Mahboubi, M. (2019) · Asian Pacific Journal of Tropical Biomedicine · doi:10.4103/2221-1691.273081 · Cited by 47 · see citing works
Assessment of Fatty Acid Beta Oxidation in Cells and Isolated Mitochondria
Rogers, G. W., Nadanaciva, S., Swiss, R. L., Divakaruni, A. S., & Will, Y. (2014) · Current Protocols in Toxicology · doi:10.1002/0471140856.tx2503s60 · Cited by 46 · see citing works
Tundis, R., Conidi, C., Loizzo, M. R., Sicari, V., & Cassano, A. (2020) · Antioxidants · doi:10.3390/antiox9070602 · Cited by 44 · see citing works
Effect of C60 fullerene nanoparticles on the diet-induced obesity in rats
Halenova, T., Raksha, N., Vovk, T. B., Savchuk, О., Остапченко, Л. І., Prylutskyy, Y. І., Kyzyma, O. A., Ritter, U., & Scharff, P. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0016-2 · Cited by 45 · see citing works
Markers of Oxidative Stress and Antioxidant Status in the Plasma, Urine and Saliva of Healthy Mice
Gyurászová, M., Kovalčíková, A. G., Janšáková, K., Šebeková, K., Celec, P., & Tóthová, Ľ. (2018) · Physiological Research · doi:10.33549/physiolres.933866 · Cited by 44 · see citing works
Baek, J.-H., Kim, D.-H., Lee, J., Kim, S., & Chun, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-020-03367-z · Cited by 44 · see citing works
Zhang, L., Chen, N., Zhan, L., Bi, T., Zhou, W., Zhang, L., & Zhu, L. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.116811 · Cited by 42 · see citing works
Tsiplakou, E., Mitsiopoulou, C., Mavrommatis, A., Karaiskou, C., Chronopoulou, E. G., Mavridis, G., Sotirakoglou, Κ., Labrou, N. E., & Zervas, G. P. (2017) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.12741 · Cited by 41 · see citing works
Huynh, T. V., Rethi, L., Rethi, L., Chen, C., Chen, Y., & Kao, Y. (2023) · Cells · doi:10.3390/cells12091223 · Cited by 40 · see citing works
Alvehus, M., Boman, N., Söderlund, K., Svensson, M., & Burén, J. (2014) · European Journal of Applied Physiology · doi:10.1007/s00421-014-2879-9 · Cited by 39 · see citing works
Alharthi, A. S., Zhou, Z., Lopreiato, V., Trevisi, E., & Loor, J. J. (2018) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-017-0221-1 · Cited by 39 · see citing works
Ezrokhi, M., Luo, S., Trubitsyna, Y., & Cincotta, A. H. (2014) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-6-104 · Cited by 39 · see citing works
Zhang, Y., Fu, Y., Jiang, T., Liu, B., Sun, H., Zhang, Y., Fan, B., Li, X., Qin, X., & Zheng, Q. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.771940 · Cited by 38 · see citing works
Savini, I., Gasperi, V., & Catani, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-19821-7_6 · Cited by 34 · see citing works
Obesity‐associated biochemical markers of inflammation and the role of grain phytochemicals
Soujanya, K. V., & Jayadeep, A. P. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14257 · Cited by 38 · see citing works
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 39 · see citing works
The obesity-autophagy-cancer axis: Mechanistic insights and therapeutic perspectives
Behrooz, A. B., Cordani, M., Fiore, A., Donadelli, M., Gordon, J. W., Klionsky, D. J., & Ghavami, S. (2024) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2024.01.003 · Cited by 37 · see citing works
Mitochondrial Dysfunction as a Factor of Energy Metabolism Disorders in Type 2 Diabetes Mellitus
Blagov, A. V., Nedosugova, L., Kirichenko, T. V., Sukhorukov, V. N., Melnichenko, A. А., & Orekhov, A. N. (2024) · Frontiers in Bioscience-Scholar · doi:10.31083/j.fbs1601005 · Cited by 41 · see citing works
Obesity, bariatric surgery and oxidative stress
Horn, R. C., Gelatti, G. T., Mori, N. C., Tissiani, A. C., Mayer, M. S., Pereira, E. A., Ross, M., Moreira, P. R., Bortolotto, J. W., & Felippin, T. (2017) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.63.03.229 · Cited by 36 · see citing works
Thioesterase-mediated control of cellular calcium homeostasis enables hepatic ER stress
Ersoy, B. A., Maner-Smith, K. M., Li, Y., Alpertunga, I., & Cohen, D. E. (2017) · Journal of Clinical Investigation · doi:10.1172/jci93123 · Cited by 36 · see citing works
Body mass index associates with white matter microstructure in bipolar depression
Mazza, E., Poletti, S., Bollettini, I., Locatelli, C., Falini, A., Colombo, C., & Benedetti, F. (2017) · Bipolar Disorders · doi:10.1111/bdi.12484 · Cited by 35 · see citing works
Kobi, J. B. B. S., Matias, A. M., Gasparini, P. V. F., Sales, S. T., Madureira, A. R., da Silva, D. S., Corrêa, C. R., Garcia, J. L., Haese, D., Nogueira, B. V., et al. (2023) · Physiological Reports · doi:10.14814/phy2.15635 · Cited by 35 · see citing works
Advances in PCOS Pathogenesis and Progression—Mitochondrial Mutations and Dysfunction
Ilie, I. R. P. (2018) · Advances in clinical chemistry · doi:10.1016/bs.acc.2018.05.003 · Cited by 35 · see citing works
Qin, H., Xu, H., Yu, L., Yang, L., Lin, C., & Chen, J. (2019) · Food & Nutrition Research · doi:10.29219/fnr.v63.3637 · Cited by 34 · see citing works
Skuratovskaia, D., Komar, A., Vulf, M., & Litvinova, L. S. (2020) · PeerJ · doi:10.7717/peerj.9741 · Cited by 35 · see citing works
Bharathi, V., Rengarajan, R. L., Radhakrishnan, R., Hashem, A., Allah, E. F. A., Alqarawi, A. A., & Anand, A. V. (2018) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2018.03.010 · Cited by 32 · see citing works
Hong, J., Fu, T., Liu, W., Du, Y., Bu, J., Wei, G., Yu, M., Lin, Y., Min, C., & Lin, D. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s456173 · Cited by 31 · see citing works
Ciccarone, F., Castelli, S., Ioannilli, L., & Ciriolo, M. R. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800970 · Cited by 30 · see citing works
Jin, H., Lee, K., Chei, S., Oh, H., Lee, K., & Lee, B.-Y. (2020) · Cells · doi:10.3390/cells9040871 · Cited by 30 · see citing works
Yoon, Y., Kim, G., Noh, M., Park, J. H., Jang, M., Fang, S., & Park, H. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00502-w · Cited by 30 · see citing works
The Effects of Maternal Obesity on Porcine Placental Efficiency and Proteome
Li, J.-W., Hu, J., Wei, M., Guo, Y., & Yan, P. (2019) · Animals · doi:10.3390/ani9080546 · Cited by 29 · see citing works
Fatty acid oxidation facilitates DNA double-strand break repair by promoting PARP1 acetylation
Yang, S., Hwang, S., Kim, B.-J., Shin, S., Kim, M., & Jeong, S. M. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05968-w · Cited by 29 · see citing works
Cheng, Y. F., Monteiro, C., Matos, A., You, J., Fraga, A. M., Pereira, C., Catalán, V., Rodrı́guez, A., Gómez‐Ambrosi, J., Frühbeck, G., et al. (2018) · Clinical Epigenetics · doi:10.1186/s13148-018-0490-3 · Cited by 29 · see citing works
Haigh, J., New, L. E., & Filippi, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.580879 · Cited by 29 · see citing works
Ku, H., Chan, T.-Y., Chung, J.-F., Kao, Y., & Cheng, C. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112440 · Cited by 29 · see citing works
Gan, L., Liu, Z., Chen, Y., Luo, D., Feng, F., Liu, G., & Sun, C. (2016) · Scientific Reports · doi:10.1038/srep36661 · Cited by 27 · see citing works
Shin, S.-K., Cho, H.-W., Song, S.-E., Bae, J., Im, S., Hwang, I., Ha, H., & Song, D. (2019) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-018-02250-3 · Cited by 27 · see citing works
Zhang, S., McMillan, R. P., Hulver, M. W., Siegel, P. B., Sumners, L. H., Zhang, W., Cline, M. A., & Gilbert, E. R. (2014) · International Journal of Obesity · doi:10.1038/ijo.2014.8 · Cited by 26 · see citing works
Park, S., Kim, Y., Lee, J., Lee, J. Y., Kim, H., Lee, S., & Oh, C. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052452 · Cited by 26 · see citing works
Cheng, Z., Schmelz, E. M., Liu, D., & Hulver, M. W. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300747 · Cited by 26 · see citing works
Tung, Y., Shih, Y.-A., Nagabhushanam, K., Ho, C., Cheng, A., & Pan, M. (2021) · Food Research International · doi:10.1016/j.foodres.2021.110143 · Cited by 25 · see citing works
Anti-obesity effects of olivetol in adult zebrafish model induced by short-term high-fat diet
Reshma, A., Tamilanban, T., Chitra, V., Subramaniyan, V., Gupta, G., Fuloria, N. K., Sekar, M., Fuloria, S., Sahu, R., Narayanan, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44462-3 · Cited by 26 · see citing works
Genomic Evidence for Bacterial Determinants Influencing Obesity Development
Isokpehi, R., Simmons, S., Johnson, M., & Payton, M. (2017) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph14040345 · Cited by 24 · see citing works
Role of Oxidative Stress on Insulin Resistance in Diet-Induced Obesity Mice
Pieri, B. L. D. S., Rodrigues, M. S., Farias, H. R., Silveira, G. D. B., Ribeiro, V. D. S. G. D. C., Silveira, P. C. L., & de Souza, C. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512088 · Cited by 24 · see citing works
Bovo, S., Mazzoni, G., Calò, D. G., Galimberti, G., Fanelli, F., Mezzullo, M., Schiavo, G., Scotti, E., Manisi, A., Samorè, A. B., et al. (2015) · Journal of Animal Science · doi:10.2527/jas.2015-9528 · Cited by 24 · see citing works
Mitochondrial function in women with polycystic ovary syndrome
Cozzolino, M., & Seli, E. U. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000619 · Cited by 24 · see citing works
Surówka, A. D., Ziomber, A., Czyżycki, M., Migliori, A., Kasper, K., & Szczerbowska‐Boruchowska, M. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.01.061 · Cited by 23 · see citing works
Li, X., He, Y., Wang, D., & Momeni, M. R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01514-w · Cited by 27 · see citing works
Ghrelin Causes a Decline in GABA Release by Reducing Fatty Acid Oxidation in Cortex
Mir, J. F., Zagmutt, S., Lichtenstein, M., García-Villoria, J., Weber, M., Gracia, A., Fabriàs, G., Casas, J., López, M., Casals, N., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-0921-3 · Cited by 15 · see citing works
Self-citationSerum levels of nesfatin-1 and irisin in obese children
Dokumacıoğlu, E., İskender, H., Şahin, A., Ertürk, E. Y., & Kaynar, Ö. (2020) · European Cytokine Network · doi:10.1684/ecn.2020.0444 · Cited by 22 · see citing works
Tung, Y., Liang, Z.-R., Chou, S.-F., Ho, C., Kuo, Y.-L., Cheng, K., Lu, T., Chang, Y., & Pan, M. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c02919 · Cited by 22 · see citing works
- Authors
- Serra, D., Mera, P., Malandrino, M. I., Mir, J. F., & Herrero, L.
- Affiliations
- Instituto de Salud Carlos III (ES)
- Corresponding author
- Herrero, Laura
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2013-07-20
- Volume
- 19
- Issue
- 3
- Pages
- 269-284
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- PMC
- PMC3691913
- OpenAlex
- W2119314929
- Semantic Scholar
- 4a19e0b958be726b0812b91b568837097ddfa0dc
- Cited by
- 246
- References
- 182
- Citations by year
- 2026: 13 · 2025: 20 · 2024: 25 · 2023: 29 · 2022: 15 · 2021: 17 · 2020: 31 · 2019: 21 · 2018: 22 · 2017: 16 · 2016: 10 · 2015: 11 · 2014: 12 · 2013: 4
- FWCI
- 0.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Antioxidants and Redox Signaling (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Dipòsit Digital de la Universitat de Barcelona (Universitat de Barcelona) (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (publishedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion)
- RECERCAT (Consorci de Serveis Universitaris de Catalunya) (submittedVersion, public-domain)
- Funders
- Eli Lilly and Company
- European Foundation for the Study of Diabetes
- Ministerio de Ciencia e Innovación (CB06/03)
- Universitat de Barcelona
- Centro de Investigación Biomédica en Red-Fisiopatología de la Obesidad y Nutrición (CB06/03)
- Instituto de Salud Carlos III (CB06/03, CB06/03/0026)
- Topics
- Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- mitochondrial fatty acid oxidation, obesity, obesity treatment, energy expenditure, liver, skeletal muscle, adipose tissue, reactive oxygen species, insulin resistance, type 2 diabetes
- MeSH terms
- Animals, Adipose Tissue, Brown, Fatty Acids, Humans, Hypothalamus, Liver, Mitochondria, Obesity, Oxidation-Reduction, Oxidative Phosphorylation, Anti-Obesity Agents, Lipid Metabolism, Adipose Tissue, White
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review